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Abstract 
Depression is associated with a number of cognitive deficits that are associated with increased 
functional impairment.  Cognitive functioning can be examined by way of subjective self-report 
measures and/or objective performance-based neuropsychological test measures grounded in 
psychometrics.  Depression is associated with impairment on objective psychometric 
neuropsychological test measures in the domains of attention, memory, executive functioning, 
and visuospatial functioning.  Using subjective self-report of cognitive functioning, depression 
has also been found to be associated with greater self-reported impairments in attention, 
memory, and executive functioning.  Previous research on the concordance between these types 
of measures has however produced mixed findings and none have made domain-specific 
comparisons.  Furthermore, if research is able to identify whether one type of measure is a better 
predictor of functional impairment, this would eliminate the need to use both types of measures, 
thereby decreasing health care costs.  The purpose of the present study was to investigate the 
concordance between objective psychometric neuropsychological test measures and subjective 
self-report of cognitive functioning and its relationship to functional impairment in depression. 
Participants included individuals who had a history of a major depressive episode or major 
depressive disorder (depressed group: 27 women, 18 men, M(age) = 34.98, SD = 15.73) and 
university students who had no history of depression (control group: 20 women, 9 men, M(age) = 
19.76 years, SD = 5.22).  Diagnoses were obtained using a semi-structured clinical interview.  
Groups were compared on psychometric measures of attention, memory, language, visuospatial 
functioning, and executive functioning using a neuropsychologist test battery and in terms of 
subjective self-report of cognitive functioning in the same domains using two self-report 
measures.  Participants also completed questionnaires that examined functional impairment, 
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severity of depression and anxiety symptoms, as well as medical and sociodemographic 
questionnaires.  Results demonstrated that the control group performed significantly worse on 
objective measures of executive functioning and self-reported greater visuospatial deficits than 
the depressed group.  Furthermore, the depressed group was found to self-report greater 
functional impairment than controls.  Within the depressed group, severity of depression was 
related to subjective attention, memory, executive functioning, and language, and functional 
impairment in all domains, but not with objective psychometric neuropsychological test 
performance.  Significant correlations were also found between objective psychometric 
neuropsychological test measures and subjective self-report of cognitive functioning in the 
domains of attention and executive functioning.  Finally, results suggest that subjective self-
report of cognitive functioning may be a better predictor of self-reported functional impairment 
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Depression is a common syndrome characterized by low mood, loss of interest, and other 
symptoms (see Appendix A for the Diagnostic and Statistical Manual of Mental Disorders 5
th
 
edition (DSM-5; American Psychiatric Association, 2013) diagnostic criteria for major 
depressive disorder and major depressive episode).  The lifetime prevalence rate of major 
depressive episode (MDE) is estimated to be between 16.6% and 19.1% in the United States 
(Kessler, Petukhove, Sampson, Zaslavsky, & Wittchen, 2012; Kessler & Üstün, 2008) and 
between 8.3% and 12.2% in Canada (Bromet et al., 2011; Patten et al., 2006).  Lifetime 
prevalence rates of major depressive disorder (MDD) are slightly lower, ranging from 13.2% to 
16.2% in the United States (Hasin, Goodwin, Stinson, & Grant, 2005; Kessler et al., 2009), and 
from 6.7% to 11% in Canada (Patten et al. 2006; Patten, 2009; Waraich, Goldner, Somers, & 
Hsu, 2004).        
The Burden of Depression 
Social and economic burden.  Although many individuals are affected by depression, 
the burden imposed by this condition goes beyond the single sufferer as it also has been shown to 
impact on society as a whole.  In 2000, the World Health Organization’s Global Burden of 
Disease study identified unipolar depressive disorders as the leading cause of YLDs (years lived 
with disability) and the fourth leading cause of disability worldwide (Üstün, Ayuso-Mateos, 
Chatterji, Mathers, & Murray, 2004).  Major depressive disorder (MDD) is projected to become 
the second leading cause of disability worldwide, second to ischemic heart disease, by 2020 
(Murray & Lopez, 1997).  The annual cost of depression in Canada is estimated to be 
approximately $51 billion, which includes direct health care costs, lost productivity on the job, 
and reductions in health-related quality of life (Lim, Jacobs, Ohinmaa, Schopflocher, & Dewa, 
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2008).  Furthermore, treatment resistant depression, which occurs in approximately 50% to 80% 
of those with depression, poses further financial burden as it has been associated with up to a 
50% increase in direct and indirect medical care costs in Canada (Olchanski et al., 2013).   
Work impairment.  One domain that is often compromised in depression and has been 
linked to significant economic burden is work performance.  The annual cost of decreased work 
productivity (presenteeism) and significant hours or days missed from work (absenteeism) has 
been estimated to be approximately $83.1 billion in the USA (Woo et al., 2000).  A study 
conducted by Gilmour and Patten (2007) found that approximately 79% of the individuals with 
depression reported that their depressive symptoms had interfered with their ability to work as 
reflected in decreased work productivity or significant absenteeism.  Individuals with depression 
are also at high risk for early termination of education, unemployment due to detrimental work 
performance (Kessler & Bromet, 2013), and increased risk of absenteeism from work 
(Broadhead, Blazer, George, & Tse, 1990).  They also experience impairments in multiple 
domains of job performance, including performance of mental-interpersonal tasks, time 
management, output, and physical tasks (Adler et al., 2006).   
Personal impairment and quality of life.  In addition to the economic and social 
burdens mentioned above, depression also presents a significant personal burden.  Individuals 
with depression often report functional impairment or limited ability to carry out certain 
functions in daily living (Üstün & Kennedy, 2009).  At an individual level, those with depression 
display poorer personal health activities, such as decreased exercise, not eating breakfast, 
irregular sleep habits, and smoking (Allgöwer, Wardle, & Steptoe, 2001).  In the social and 
family domains, depression is associated with a number of difficulties which may negatively 
affect quality of life, such as poorer family functioning (Weinstock, Keitner, Ryan, Solomon, & 
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Miller, 2006), marital dissatisfaction and discord (Coyne, Thompson, & Palmer, 2002; Kessler & 
Bromet, 2013), and poorer parent-child relationships (Kessler and Bromet, 2013) that can lead to 
future adolescent problem behaviours, including the development of antisocial behaviours 
(Deković, Janssens, & van As, 2003).  Depression can also negatively affect the quality of 
relationships with friends (Johnson, Meyer, Winett, & Small, 2000; Mickelson, 2001; Nasser & 
Overholser, 2005; Windle, 1994).  
Not only do individuals with depression display functional impairments in their daily 
lives, they also perceive themselves to be functionally impaired.  Subjective quality of life 
(QOL) refers to an individual’s “subjective perception of his or her physical health, 
psychological health, social functioning, environment, and general life quality” (Kuehner & 
Buerger, 2005, p. 206) and has been identified as an important outcome measure in those with 
mental illnesses (IsHak et al., 2011).  Overall, those with depression tend to report poorer quality 
of life than nondepressed individuals (Brenes 2007; Daly et al., 2010; Kuehner & Buerger, 2005; 
Rapport, Clary, Fayyad, & Endicott, 2005). 
Cognitive Deficits in Depression 
Cognitive deficits are one of the key characteristics in depression expressed as a 
“diminished ability to think or concentrate, or indecisiveness, nearly everyday” (DSM-5, APA, 
2013, pg. 161) and have been explicitly identified as a significantly disabling aspect of the 
disorder as early as 1952 (Madden, Luban, Kaplan & Manfredi, 1952).  Cognition has been 
described as the “process of knowing” (Gazzangia, Ivry, & Mangun, 2009, p. 2) and includes a 
number of mental functions including awareness, perception, memory, attention, and reasoning.  
Research suggests that 60% to 90% of individuals with depression experience impairments in 
cognitive functioning (Alfridi, Hina, Qureshi, & Hussain, 2011; Gaynes et al., 2007).  
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Direct cost estimates of the cognitive deficits associated with depression have not been 
adequately evaluated (Mackin, Delucchi, Bennett, & Areán, 2011).  However, cognitive deficits 
associated with depression have been linked to other factors that have the potential to 
significantly increase both personal and mental healthcare costs, such as increases in health 
services utilization (Xiang & An, 2015) and disruptive job performance (McIntyre et al., 2013).  
A number of studies (Conradi, Ormel, & de Jonge, 2011; Fava, Ruini, and Belaise, 2007; 
Hasselbalch, Knorr, Hasselbalch, Gade, & Kessing, 2012; Nierenberg et al., 1999; Potter, 
Kittinger, Wagner, Steffens, & Kristnan, 2004; Rock, Roiser, Riedel, & Blackwell, 2014) have 
also shown that the cognitive deficits associated with depression are resistant to treatment even 
after symptomatic remission has been achieved, and that these cognitive symptoms continue to 
interfere with daily functioning (Lam, Kennedy, McIntryre, & Khullar, 2014).  Furthermore, 
residual symptoms have been associated with risk of relapse in depression (Paykel, 2008).  
Interestingly, other research shows that the pattern of cognitive functioning during the 
different phases of unipolar and bipolar depression is similar.  For example, several studies have 
reported no significant difference in the self-rated experience of cognitive functioning or 
performance on objective psychometric neuropsychological tests during the euthymic (i.e. 
asymptomatic) phase in unipolar and bipolar depression (Kessing 1998; Marvel & Paradisø, 
2004; Miskowiak, Vinberg, Christensen & Kessing, 2012; Quraishi & Frangou, 2002).  Although 
there is sparse research comparing the cognitive deficits present during the depressive phase of 
unipolar and bipolar disorders, the available results suggest similar results.  One review (Cueller, 
Johnson, & Winters, 2010) suggests that both patients with bipolar and unipolar depression 
display negative cognitive styles during depressive episodes, including lowered self-esteem and 
increased distraction from negative words of the Stroop task, but that this negative thinking style 
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diminishes during euthymic periods for those with bipolar but not unipolar depression.  A more 
recent study conducted by Godard, Baruch, Grondin, and Lafluer (2012) found that patients with 
unipolar and bipolar depression who were currently in a depressive phase displayed similar 
neurocognitive profiles with the most frequently impaired cognitive domains being alertness, 
information processing speed, sustained and divided attention, and spontaneous flexibility.  
Taken collectively, these results show that there are no significant differences in cognitive 
functioning between patients with unipolar and bipolar depression during the depressive phase 
(i.e. those currently experiencing an MDE) and the euthymic phase (i.e. those not currently 
experiencing an MDE).  This suggests that research and treatment aimed at ameliorating the 
cognitive deficits seen in depression may be applicable to, and beneficial for, patients with both 
unipolar and bipolar depression. 
Other research suggests that cognitive deficits may play an important role in functional 
recovery (i.e., improvement in life functioning) for patients with depression.  In support of this, 
Jaeger, Berns, Uzelac, and Davis-Conway (2006) found that in a sample of patients hospitalized 
for MDD, cognitive deficits in the domains of visuospatial functioning, learning, and motor 
measures were predictive of functional recovery six months after discharge and that in five out of 
seven cognitive domains, the presence of cognitive deficits were significantly associated with 
functional disability, after controlling for residual depressive symptoms and psychosis.  The 
authors also found that cognitive improvement over time was associated with a higher likelihood 
of functional recovery and those who showed no improvement or worse cognitive functioning 
were more likely to be significantly or totally disabled.  
Taken together, the literature suggests that cognitive impairments seen in depression are 
associated with poorer outcomes and significant personal and mental healthcare costs.  However, 
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despite the fact that impaired cognition is a core symptom of depression and that research has 
established a link between cognitive impairment and functional outcomes in depression, 
cognitive issues often do not receive specific attention in assessment and treatment by mental 
health professionals (Greer, Kurian, & Trivedi, 2010).  Since cognitive symptoms play an 
important role in improving functional outcomes for patients with depression, this area is a 
valuable target for future interventions (Rock et al., 2014).  
Factors Affecting Cognitive Performance in Depression 
A number of factors have been found to influence the extent and manifestation of 
cognitive impairment in individuals with depression, including severity of depression and age. 
Studies assessing the nature and extent of cognitive impairment in depression should take these 
factors into account.  
Severity of depression.  Although findings have been conflicting, there is some evidence 
of consistent patterns between severity of depression and extent of cognitive impairment (Austin, 
Mitchell, & Goodwin, 2001).  For example, in one study (Naismith et al., 2003) individuals 
diagnosed with severe depression scored significantly lower on a test of semantic fluency, had 
more perseverative errors on the Wisconsin Card Sorting Test, and had lower scores on the Rey 
Auditory Verbal Learning Test.  Thus, greater severity of depression was associated with greater 
impairment in attention, executive functioning, and verbal memory.  In their meta-analysis 
analyzing depression severity and cognitive dysfunction, McDermott and Ebmeier (2009) found 
significant negative correlations between depression severity and the cognitive domains of 
episodic memory, executive functioning, and processing speed.  Greater severity of depression is 
also associated with poorer performance on visuospatial tasks such as visuospatial and pattern 
recognition and delayed matching (Porter, Gallagher, Thompson, & Young, 2003).  Thus, those 
ASSESSING COGNITIVE FUNCTIONING IN DEPRESSION  
 
7 
with more severe depression show greater deficits in attention, memory, visuospatial functioning, 
executive functioning, and processing speed.  
Age.  Age is another factor that can profoundly influence performance on cognitive tasks.  
Studies have documented the finding that cognitive performance, especially psychomotor speed, 
declines with age, independent of depression (Harada, Natelson, & Triebel, 2013; Salthouse, 
2012).  Other research suggests that that late-life depression is associated with a distinct profile 
of cognitive deficits that differs from that of younger individuals with depression.  In support of 
this, Fossati, Coyette, Ergis, and Allilaire (2002) found a significant effect of age on verbal 
memory performance in young and elderly patients with depression, with elderly patients 
performing more poorly than younger patients on a verbal memory task.   
Research on Cognitive Deficits in Depression 
Research on cognitive deficits in depression has used subjective self-report of cognitive 
functioning or objective psychometric neuropsychological test measures.  Self-report measures 
are questionnaires that are completed either by the individual or a collateral informant and are 
considered to be subjective measures because they measure the individual’s subjective 
experience of cognitive functioning as reported by the self or another party.  Self-report 
questionnaires can be direct or have high face validity in which the person being assessed is 
aware of the construct being measured, or indirect or have low face validity in which the 
construct being measured is obscured (Paulhus & Vazire, 2009).  Self-report measures are often 
used in clinical settings because they are inexpensive and easy to administer.  However, a serious 
limitation to self-report measures is that they suffer from limited reliability and validity (Priddy, 
Mattes, & Lam, 1988; Tanaka-Matsumi & Kameoka, 1986).  One issue is that patients’ response 
sets may influence the reliability of self-report measures.  Specifically, patients may over-report 
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or under-report their symptoms for a variety of reasons (e.g. social desirability, inconsistency of 
responses due to negligence) and these effects may be exaggerated on highly face-valid self-
report measures (Murphy & Davidshofer, 2005).  Despite their limitations, self-report measures 
of cognitive symptoms are an important indicator of neuropsychological functioning because 
they communicate an individual’s perception of his or her neuropsychological impairments or 
deficits and their impact on everyday activities (Gordon, Haddad, Brown, Hibbard, & Sliwinski, 
2000).  
Cognitive functioning in depression can also be examined using objective psychometric 
neuropsychological test measures.  Neuropsychological assessment can be defined as “a 
performance-based method to assess cognitive functioning and is performed with a battery 
approach, which involves a variety of cognitive ability areas” (Harvey, 2012, p. 91).  These tests 
are considered objective because they make use of normative comparison stratified by various 
demographic variables, such as age, sex, and education, based on standardized samples.  There 
are several specific uses of neuropsychological assessment, including collection of diagnostic 
information, differential diagnostic information, assessment of treatment response, and 
prediction of functional potential and functional recovery.  Neuropsychological testing has 
important practical implications in depression treatment settings.  Results from these types of 
tests can inform treatment planning which might be tailored in accordance with patients’ 
identified cognitive strengths and weaknesses with the hope of improving treatment response and 
outcome.  
In primary care settings, objective psychometric neuropsychological test measures are not 
routinely used due to lack of consensus about their relevance (Svendsen, Kessing, Munkholm, 
Vinberg & Miskowiak, 2012), as well as time and resource (i.e. cost and labour) restraints 
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(Grohman & Fals-Stewart, 2004).  Rather, assessment of cognitive complaints is usually 
achieved by use of subjective self-report.  This may be problematic since patients with 
depression are prone to cognitive biases in their thinking (Joormann, Waugh, & Gotlib, 2015), 
which can affect their subjective self-report.  Research shows that the cognitive deficits 
associated with depression impacts upon quality of life and daily social and occupational 
functioning (Jaeger et al., 2006), thus highlighting the need for paying closer attention to 
cognitive functioning in assessment and treatment processes in order to improve patient 
functioning and reduce risk of relapse.  Examination of the relationship between subjective self-
report of cognitive functioning and objective psychometric neuropsychological test measures in 
patients with depression is important to clarify whether patients’ self-reported cognitive 
complaints reflect underlying objective performance-based deficits.  This would help inform 
clinicians about whether they can rely on patients’ cognitive complaints or, on the other hand, 
would need to implement an objective neuropsychological assessment to guide diagnostic and 
treatment efforts. 
Findings from subjective self-report of cognitive functioning.  The most common self-
reported cognitive deficits in depression are attention/concentration and memory (Gaynes et al., 
2007).  In a study of 164 outpatients with depression, 96% noted difficulty concentrating and 
93% reported problems with memory.  Furthermore 52% of these patients perceived these 
cognitive symptoms as interfering substantially with their occupational functioning (Lam et al., 
2012)  
The presence of memory and attentional complaints also differentiates individuals with 
depression from nondepressed, healthy controls.  Those with depression are more likely to have 
subjective memory complaints than nondepressed controls (Antikainen et al., 2001).  These 
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memory problems were rated as less severe with the improvement of depressed mood over time.  
Naismith, Longlet, Scott, and Hickie (2007) found that patients meeting criteria for an MDE 
rated themselves as experiencing higher levels of cognitive dysfunction in the domains of speed, 
concentration, and short-term memory than nondepressed controls.  Thus, it appears that 
subjective memory complaints are directly related to the presence and severity of depressive 
symptoms. 
In sum, depression is associated with a number of self-reported cognitive complaints, 
most notably in the domains of memory and attention.  No studies have looked at subjective self-
reported cognitive complaints associated with depression in visuospatial and executive 
functioning domains.  Although self-report measures suffer from a number of limitations, their 
use does offer a number of benefits for the assessment of cognitive functioning in depression. 
Notably, they communicate an individual’s subjective perception of his or her impairments or 
deficits. 
Findings from objective psychometric neuropsychological test measures.  There is 
ample research on cognitive functioning in depression using objective psychometric 
neuropsychological test measures.  Many studies have used full neuropsychological batteries, 
while others have used only a few subtests from these batteries to tap into the various cognitive 
domains.  Overall, the empirical research on objective performance-based cognitive deficits in 
depression has led to inconsistent results.  This is likely due to differences across studies in 
sample characteristics (depression subtype, severity) as well as methods used to assess cognitive 
dysfunction (Burt, Zembar, & Niedereche, 1995; Zakzanis, Leach, & Kaplan, 1998).  Despite 
these inconsistencies, important patterns have emerged.  Neuropsychological deficits in 
depression occur in the domains of attention, memory, visuospatial functioning, and executive 
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functioning (Alfridi et al., 2011; Papakostas, 2014; Rock et al., 2014; Zakzanis et al., 1998).  A 
comprehensive review conducted by Ottowitz, Dougherty, and Savage (2002) revealed that 
cognitive deficits in unipolar depression were reported by half of the studies that used 
performance-based attention tests and by over 90% of studies that used demanding, ‘pre-frontal’ 
executive functioning tests.   
Attention.  Impaired attention is considered to be one of the cardinal features of 
depression (Mialet, Pope, & Yurgelun-Todd, 1996).  According to Lezak, Howieson, and Loring 
(2004), attention is defined as “several different capacities or processes that are related aspects of 
how the organism becomes receptive to stimuli and how it may begin processing incoming or 
attended-to excitation” (p. 34).  Attention can include both automatic (involuntary) and 
deliberate (voluntary) processes.  Research on perceptual load and the influence of distractors 
has shown that an important characteristic of attention is its limited capacity (e.g. Lavie, 2005).  
There are many conceptualizations of the different types of attention; however Lezak et al. 
(2004) have identified and described five important domains of attention.  Immediate span of 
attention involves the amount of information that can be grasped at once.  Focused or selective 
attention refers to an individual’s ability to process one or two events or stimuli to the detriment 
of others.  Tests that tap this domain often require individuals to attend to certain stimuli while 
rejecting stimuli that are irrelevant.  Sustained attention, also called vigilance, involves 
maintaining attention on an activity over some time period.  Divided attention involves the 
ability to engage and respond to several tasks at the same time.  Tasks that tap this domain often 
require individuals to engage in more than one cognitive task simultaneously.  Alternating 
attention refers to the ability to shift focus in alternating tasks.   
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One of the most basic neuropsychological tests that is routinely used to assess attentional 
abilities is the Digit Span Test.  In the Digit Span Test, individuals listen to a series of digits 
presented verbally by the examiner and are required to repeat them back. This test measures 
immediate auditory attentional capacity and immediate recall.  Numerous studies have found that 
those with MDD perform significantly worse on the Digit Span Test than healthy controls 
(Fossati, Amar, Raoux, Ergis & Allilaire, 1999; Lim et al., 2013; Martin, Oren, & Boone, 1991).  
Depression has been found to be associated with deficits in selective attention, sustained 
attention, and divided attention.  In terms of selective attention, several studies have found that 
individuals with depression show a negative cognitive bias in that they are more likely to attend 
to negative stimuli rather than positive or neutral stimuli (e.g. Harmer, Goodwin, & Cowen, 
2009; Joorman & Gotlib, 2007; Joormann, et al., 2015; Koster, Raedt, Goeleven, Franck, & 
Crombez, 2005; Mathews, Ridgeway, & Williamson, 1996; Rinck & Becker, 2005; Surguladze 
et al., 2005).  Depression is also associated with deficits in sustained attention.  Specifically, 
people with depression show more errors of omission and commission and display longer 
reaction times on a continuous performance task that requires participants to respond to specific 
stimuli contained within a string of serially presented letters (Gualtieri, Johnson, & Benedict, 
2006; Lim et al., 2013; Porter et al., 2003).  Furthermore, using the Sustained Attention to 
Response Task (SART), which measures vigilance, Farrin, Hull, Unwin, Wykes, and David 
(2003) found that the group with depression made more errors on the task than did the non-
depressed controls, suggesting that individuals with depression have impairments in sustaining 
their attention.  Using a dual task paradigm, a test of divided attention which requires 
participants to simultaneously pay attention to two different stimuli and respond only to target 
stimuli, Majer et al. (2004) found that participants with depression were slower to react to target 
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stimuli than non-depressed controls. Digit Span Backwards, which requires individuals to repeat 
numbers in the reverse order of presentation, and is another measure of divided attention, has 
also been found to differentiate between individuals with depression and controls (Majer et al. 
2004; Stordal et al., 2004).  Finally, cognitive deficits in depression have also been shown with 
the use of the letter cancellation task, which measures sustained attention, selective attention, and 
psychomotor speed.  For this task, individuals must cancel or cross out one or more target letters 
in a sequence of random letters and/or numbers within a certain amount of time.  Several studies 
utilizing different versions of the letter cancellation task have shown that individuals with 
depression score significantly lower on the task than healthy controls (Agarwal, Kalra, Natu, 
Dadhich, & Deswal, 2002; Zakzanis et al., 1998).   
Taken together, these results suggest that depression is associated with quantifiable 
deficits in selective, sustained, and divided attention.  Specifically, individuals with depression 
are less able to divide their attention as needed, are less able to sustain their attention, and often 
show attentional biases that influence what information they attend to.  This may explain why 
concentration complaints are so common for this population. 
Memory.  In addition to attentional problems, depression is also commonly associated 
with a number of memory deficits.  At a general level, research has established that there are a 
number of distinct memory systems (Squire & Knowlton, 2000).  One important distinction is 
between explicit and implicit memory.  Explicit memory, also referred to as declarative memory, 
involves knowledge that is consciously available, whereas implicit memory involves knowledge 
that is not consciously available but is often expressed in performance (Lezak et al., 2004).  
Depression is associated with impairments in declarative memory (Marvel & Paradisø, 2004; 
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Zakzanis et al., 1998); however, implicit memory does not seem to be affected in depression 
(Ellwart, Rinck, & Becker, 2003; Ilsley, Moffoot, & O’Carroll, 1995). 
Another important distinction is that between verbal and visual (nonverbal) memory.  
Verbal memory is typically assessed using stimuli consisting of words, sentences and 
paragraphs.  Several studies have shown that depression is associated with impaired verbal 
memory (e.g. Burt et al., 1995; Hammar, Isaksen, Schmid, Årdal, & Strand, 2011; Hermens, 
Naismith, Hodge, Scott, & Hickie, 2010).  Specifically, compared to healthy controls, 
individuals with depression recall fewer words on immediate recall and show deficits in story 
learning and recall (Hammar et al., 2011; Watts & Cooper, 1989).   
Visual memory has also been found to be impaired in individuals with depression and is 
examined using visual designs, spatial positions, and faces (Sohlberg & Mateer, 2000).  Visual 
memory is often assessed using the Rey-Osterrieth Complex Figure Task, in which individuals 
are asked to copy, recall and recognize elements from a complex figure.  Using this task, several 
studies have found that individuals with depression performed significantly worse than controls 
in delayed recall and recognition (Behnken et al., 2010; Hammar et al., 2011; Hammar & 
Schmid, 2013).  One study using the Rey-Osterrieth Complex Figure Task found that individuals 
with depression recalled significantly fewer parts of the figure, and had lower total recognition 
scores, compared to healthy controls (Hammar et al., 2011).  Furthermore, research suggests that 
patients with depression are more likely to show impairments in recall, rather than recognition, 
as the latter is considered to be more cognitively demanding (Brand, Jolles, & Gispen-de Wied, 
1992).  Other frequently used visual memory tasks used to assess cognitive deficits in depression 
include the delayed match to sample and paired associated learning subtests of the Cambridge 
Automated Neuropsychological Test Battery (CANTAB; Fray, Robbins, & Sahakian, 1996; 
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Sahakian et al., 1988), which tap into delayed visual recognition and simple visual pattern and 
associative learning respectively.  Using these subtests, Egerhazi et al. (2013) found that 
individuals with depression performed more poorly than healthy controls.  Greater severity of 
depression is also associated with poorer memory performance on visuospatial tasks such as 
spatial and pattern recognition and delayed matching (Porter et al., 2003).  Thus, depression is 
associated with impairment in a number of different types of memory including verbal and visual 
memory.   
Visuospatial functioning.  Another area in which deficits are commonly seen in 
depression is in visuospatial functioning (Asthana, Mandal, Khurana, & Haque-Nizamie, 1997).  
Visuospatial functioning includs a “constellation of complex visual processing abilities, 
including spatial awareness and attention, awareness of self-other and of self-object spatial 
relationships, visuospatial memory, and interpretation and navigation of extrapersonal space” 
(Arciniegas, McAllister, & Kaufer, 2007, p. 67).  Three important aspects of visuospatial 
functioning include perceptual, constructional, and spatial awareness skills (Mapou, 1995).  
Perceptual skills refer to the initial processing of visuospatial information that occurs beyond the 
basic sensory level but is separate from motor responses; thus, these skills involve the input of 
visuospatial information.  Constructional skills reflect both input (e.g., basic visual skills such as 
seeing and perceiving a drawing) and output skills (e.g., basic motor and organizational skills, 
such as copying a drawing).  Spatial awareness refers to an individual’s awareness of intra- and 
extra-personal space and reflects both input and output of visuospatial information.  Deficits in 
spatial awareness are often seen as disruptions in functional skills, such as following directions.  
All three aspects are important contributors to one’s overall visuospatial functioning. 
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In terms of visuospatial perceptual skills, individuals with depression show deficits in 
rapid visual processing (Egerhazi et al., 2013).  Further supporting this, other research has 
demonstrated that a deficit of the right posterior hemisphere, which is predominantly responsible 
for the processing of visuospatial information, is involved in depression (Keller et al., 2000).  
Additionally, Nissen et al. (2010) found that patients with depression showed impaired 
performance on a visual texture discrimination task compared to controls.  Finally individuals 
with depression performed more poorly than nondepressed controls on the line orientation task, 
which involves the identification of two target lines out of an array of lines (Baune 2010; Coello, 
Ardila, & Rosselli, 1990). Thus, it appears that individuals with depression are less able to 
process and discriminate visuospatial information than their healthy counterparts. 
Deficits are also seen in constructional and spatial awareness skills.  For example, 
individuals with depression also show impaired visual tracking and scanning abilities (Veiel, 
1997) and are less able than controls to accurately copy a drawing on the Rey-Osterrieth 
Complex Figure Task (Baune et al., 2010; Rossi et al., 1990).  Deficits have also been found 
using the Block Design Task (Gorlyn, et al., 2006; Veiel al., 1997), suggesting that individuals 
with depression may have difficulties in assembling objects and following instructions, which 
are both part of constructional and spatial awareness skills. 
Finally, research has also found that compared to healthy controls, individuals with 
depression are more impaired on tasks of visuospatial learning and memory (Porter et al., 2003).  
Specifically, people with depression are more likely to complete fewer trials of a paired-
associated learning task, which requires participants to learn and replicate the matching of two 
complex stimuli to spatial locations on a screen, and are also less able to learn and later 
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remember patterns, object stimuli, and spatial positions of stimuli (Beblo, Baumann, Bogerts, 
Wallesch, & Herrmann, 1999; Porter et al., 2003). 
In sum, the deficits seen in depression seem to reflect impairments in a number of 
visuospatial domains including perceptual, constructional, and spatial awareness skills.  However 
some of these areas may overlap with other cognitive domains.  For example, the deficits seen in 
visuospatial learning and memory may be due to a more general memory impairment.  
Furthermore, rapid visual processing, tracking and scanning deficits may be linked to attentional 
difficulties.  Thus, although depression is associated with a number of visuospatial deficits, at 
least some of these may be due to more broad attentional and memory impairments.  
Executive functioning.  Executive functioning (EF) is another domain in which deficits 
associated with depression are found.  EF has been defined in a number of different ways.  Most 
definitions of EF propose that EF includes self-regulated, higher-level cognitive processes that 
control and regulate lower, more automatic processes towards goal-directed behavior (Snyder, 
2013).  Inherent in these definitions is the notion that higher-level cognitive processes are 
distinct from automatic processes.  Across models of EF, it is recognized that although there is a 
unitary aspect of EF, a number of these components are separable (e.g. Friedman et al., 2008; 
Miyake, Friedman, Emerson, Witzki, & Howerter, 2000). Empirical studies have found evidence 
of EF deficits due to depression on measures of verbal fluency, set-shifting, planning, executive 
control of attention, emotional salience, and response bias (Rogers et al., 2004).  
Two areas of EF that have received a significant amount of attention in the depression 
literature are verbal fluency and planning.  Verbal fluency refers to the ability to generate words 
from either semantic categories (semantic verbal fluency) or starting with certain letters 
(phonemic verbal fluency) within a specified time limit (Snyder, 2013).  Significant impairments 
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have been found in patients with MDD on tasks of both semantic and phonemic verbal fluency 
(e.g. Henry & Crawford, 2005; Zakzanis et al., 1998), with individuals with depression 
generating fewer words.  
A second important area of EF, planning, is defined as identifying and organizing a 
sequence of steps to achieve a goal (Lezak et al., 2004).  Planning is often measured using the 
Tower of London Task (Shallice, 1982), in which individuals must move beads across pegs from 
a starting position to a target position in as few moves as possible while following a set of rules.  
Using this test, individuals with depression have been found to be less accurate than healthy 
controls and this performance varied with the level of difficulty of the task.  That is, the 
individuals with depression showed greater impairment on the more difficult tasks (Naismith et 
al., 2003).    
In sum, research has looked at specific cognitive deficits associated with depression in 
the domains of attention, memory, visuospatial functions, and executive functioning. Using a 
variety of tasks in each of these domains, the literature supports the notion that depression is 
linked to a variety of cognitive deficits.  
Comparison of Findings from Subjective Self-report of Cognitive Functioning and 
Objective Psychometric Neuropsychological Test Measures 
Understanding the relationship between subjective self-report of cognitive functioning 
and objective psychometric neuropsychological tests in depression is important because of its 
relevance to clinical treatment.  Patients without awareness of their cognitive deficits can lack 
motivation for treatment, fail to utilize recommended compensatory strategies, set unrealistic 
goals, or experience difficulties with social adaptation (McGlynn & Schacter, 1989; Wagner & 
Cushman, 1994).  Alternatively, cognitively intact patients who perceive themselves as 
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cognitively impaired could report themselves as such, resulting in incorrect diagnoses or 
inappropriate treatments.  Furthermore, self-report of cognitive functioning are often affected by 
the presence of other conditions such as schizophrenia, in which lack of insight is a key 
symptom, and as a result may not have the same value as objective performance-based measures 
(Bowie et al., 2007). 
Various studies have investigated the relationship between subjective self-report of 
cognitive functioning and objective psychometric neuropsychological test measures in 
depression and have produced mixed findings.  Hueng et al. (2011) found that subjective self-
report of cognitive functioning and objective psychometric neuropsychological test measures 
were correlated for Taiwanese individuals with depression in the domains of sustained attention, 
memory, and executive functioning but not for psychomotor speed.  However, the authors noted 
the limitation of their findings due to their small sample size.  Another study found that in a 
population of Finnish patients with depression, subjective memory complaints were significantly 
correlated with their objective performance on neuropsychological memory tests (Antikainen et 
al. 2001).  In contrast, Svendsen et al. (2012) found that patients with MDD self-reported greater 
cognitive deficits and performed more poorly on objective psychometric neuropsychological test 
measures compared to the control group but that there was no correlation between the total 
scores on these two types of measures.  Furthermore, they found that severity of depression 
predicted general subjective self-report of cognitive functioning but not objective psychometric 
neuropsychological test findings.   
The absence of a concordance between subjective self-report of cognitive functioning and 
objective psychometric neuropsychological test measures has been found for a number of other 
psychiatric and medical disorders such as substance abuse (Horner, Harvey, & Denier, 1999), 
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multiple sclerosis (Julian, Merluzzi, & Mohr, 2007), bipolar disorder (Burdick, Endick, & 
Goldberg, 2005; van der Werf-Eldering et al., 2011), and schizophrenia (Tomida et al., 2010). 
In sum, it appears that the literature is divided, with some studies finding a relationship 
between objective psychometric neuropsychological test measures and subjective self-report of 
cognitive functioning depression, while others do not.  A major issue with the research 
conducted to date on the relationship between these types of measures in depression is the large 
variation in both the patient samples (see Hueng et al. 2011; Antikainen et al. 2001) and the 
neuropsychological batteries used to assess cognitive impairment (Russo, Mahon, & Burdick, 
2014).  Furthermore, the objective psychometric neuropsychological test measures and 
subjective self-report measures that are used to assess cognitive functioning may not directly 
map onto each other.  For example, in the study conducted by Svendsen et al. (2012), subjective 
experience of cognitive difficulties was measured using the Massachusetts General Hospital 
Cognitive and Physical Functioning Questionnaire (CPFQ; Fava et al., 2006), which assesses the 
following subcategories: Apathy/Motivation, Wakefulness/Alertness, Energy Level, 
Focus/Sustain Attention, Memory/Recall, Word Finding Ability and Sharpness/Mental Acuity 
(Fava et al., 2009).  Meanwhile, objective cognitive performance in this study was measured 
using the Screen for Cognitive Impairment in Psychiatry (SCIP), which assesses the following 
cognitive domains: verbal learning and memory, delayed memory, working memory, verbal 
fluency and processing speed, but not attention (Purdon, 2005).  Therefore, the extent to which a 
consensus about the relationship between subjective self-report of cognitive functioning and 
objective psychometric neuropsychological test measures in depression can be drawn from these 
results is limited.  This issue can be addressed with studies in which these different types of 
measures assess the same domains of cognitive functioning.  
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As the need for more inexpensive means of evaluation and treatment in the health care 
system increases, research on the concordance between subjective self-report of cognitive 
functioning and objective psychometric neuropsychological test measures has become more 
important.  This type of investigation is important to elucidate whether or not self-reported 
cognitive difficulties reported by patients with depression can be used in place of more expensive 
and time-intensive objective neuropsychological assessments, or whether these types of 
measures provide different information to guide treatment strategies. 
The Relationship between Measures of Cognitive Functioning and Functional Impairment  
 Research shows that depression is associated with high levels of impairment and poorer 
quality of life (Brenes 2007; Daly et al., 2010; Kuehner & Buerger, 2005; Rapport et al., 2005).  
Depression is also associated with both objective performance-based and subjective self-reported 
cognitive impairment, as discussed above.  That is, individuals with depression show poorer 
performance on objective psychometric neuropsychological test measures and also rate their 
cognitive functioning as worse than nondepressed controls on subjective self-report.  However, 
the research that examines the link among depression, cognitive measures, and functional 
impairment is sparse.  Specifically, there is a lack of studies investigating which domains of 
either subjective self-rated cognitive functioning or objectively measured cognitive performance 
are associated with functioning in daily life (Svendsen et al., 2012).  If research findings are able 
to identify which type of measurement is a better predictor of functional impairment, then this 
would eliminate the need to use both types of measures, thereby decreasing health care costs. 
 Research has shown that subjective self-reported complaints of cognitive functioning in 
depression are related to greater impairment.  Individuals with depression who have memory 
complaints are more likely than depressed individuals without memory complaints to rate their 
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health status and psychosocial functioning as poor (Antikainen et al., 2001).  Another study 
found that 52% of patients with depression who had self-reported memory problems also 
perceived these symptoms as interfering substantially with their occupational functioning (Lam 
et al., 2012).   
A study by Naismith et al. (2007) looked at how subjective self-report of cognitive 
functioning and objective psychometric neuropsychological test measures relate to physical, 
mental, and functional impairment among individuals with depression.  The authors found that 
objective psychomotor speed was related to limitations of physical activities (such as climbing 
stairs) and objective memory retention was related to functional impairment (i.e. how many days 
the individual was unable to carry out their usual activities).  Performance on objective 
psychometric neuropsychological test measures did not predict mental health functioning 
(motivation, efficiency for engagement in daily activities, quality of social relationships).  
Subjective self-report ratings of overall cognitive dysfunction were strongly related to physical 
limitations, while deficits in self-rated speed, short-term memory, and overall cognitive 
functioning were related to functional impairment.  Furthermore, self-rated deficits in speed, 
short-term memory, concentration, and overall cognitive functioning were related to 
compromised mental health functioning.  However, mental health functioning was not related to 
any objective psychometric neuropsychological test measures.  Overall, findings from this study 
suggest that objective psychometric neuropsychological test measures and subjective self-report 
of cognitive functioning might predict different forms of impairments and limitations in 
depression.   
 
 




 Individuals with depression report functional impairment (Üstün & Kennedy, 2009) and 
compromised quality of life (Brenes 2007; Daly et al., 2010; Kuehner & Buerger, 2005; Rapport 
et al., 2005).  Cognitive deficits are part of the clinical presentation of depression (Gaynes et al., 
2007), contribute to functional impairment (McIntyre et al., 2013), and persist even after 
treatment (Fava et al., 2007) in some individuals.  This underscores the importance of studying 
cognitive deficits in depression as the remediation of these deficits can lead to improved 
outcomes for patients with depression.  Cognitive deficits can be measured through subjective 
self-report or objective psychometric neuropsychological test measures.  Examinations on the 
degree of concordance between these types of measures have produced mixed findings.  Some 
studies find no concordance (Svendsen et al., 2012) while others report that it depends on the 
type of cognitive domain under investigation (Hueng et al., 2011).  Furthermore, there is some 
evidence to suggest that objective psychometric neuropsychological test measures and subjective 
self-report of cognitive functioning are related to physical and mental health impairment, 
respectively, and that both are related to functional impairment (Naismith et al., 2007).  Most of 
the research to date has focused on the use of objective psychometric neuropsychological test 
measures and functional impairment, but relatively little work has looked at subjective self-
report of cognitive functioning in depression.  Similarly, there is scant investigation on the direct 
comparison of objective psychometric neuropsychological test measures and subjective self-
report of cognitive functioning in depression. 
Purpose of the Present Study 
The purpose of the present study was to examine the concordance between objective 
psychometric neuropsychological test measures and subjective self-report of cognitive 
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functioning and its relationship to functional impairment (in work, social life, family life) in 
depression.  The domains of cognitive impairment examined were attention, memory, language, 
visuospatial functioning, and executive functioning.  Participants consisted of individuals 
between the ages of 18 and 65 with a history of depression (depressed group) and nondepressed 
individuals (control group).   
It was hypothesized that: 
i) The depressed group would perform more poorly than the control group on objective 
psychometric neuropsychological test measures in the domains of attention, memory, 
visuospatial functioning, and executive functioning.  
ii)  The depressed group would report greater impairment than the control group on 
subjective self-report of cognitive functioning in the domains of attention, memory, 
and executive functioning. 
iii) The depressed group would report greater functional impairment than the control 
group in work, social life, and family life.  
It was also expected that within the depressed group: 
iv) Greater severity of depression symptoms would predict poorer performance in 
objective psychometric neuropsychological test measures in the domains of attention, 
memory, visuospatial functioning, and executive functioning and greater self-rated 
cognitive dysfunction in the domain of memory. 
v) There would be a positive correlation between subjective self-report of cognitive 
functioning and objective psychometric neuropsychological test measures in the 
domains of attention, memory, and executive functioning.  
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vi) Poorer performance on objective psychometric neuropsychological test measures 
would predict greater functional impairment associated with work. 
vii) Poorer subjective self-report of cognitive functioning would predict greater functional 
impairment in all domains (work, social life, family life). 
Method 
The data for this project was derived from a larger study that was conducted at two sites: 
the START Clinic for Mood and Anxiety Disorders, a tertiary care clinic located in Toronto, 
Ontario, and the University of Toronto, Scarborough Campus (UTSC).  The project received 
ethics clearance from Optimum Ethics Review Board (see Appendix B) and the UTSC research 
ethics board (see Appendix C).  The researcher for this project (R. Tzalazidis) was part of the 
team for the study and was principally involved in the recruitment and assessment of participants 
and in the data collection.   
Participants 
 In total, 101 individuals participated in the study (61 women, 40 men), with 53 
individuals recruited from the START Clinic and 49 recruited from UTSC.  All participants were 
between 18 and 65 years old (mean age = 31.71 years, SD = 15.31).  These age limits were 
chosen because the START Clinic only assesses patients who are aged 18 or older, and late-life 
depression (above age 65) is associated with a distinct profile of cognitive deficits that differs 
from that of younger individuals with depression (Fossati et al., 2002).  Participants with a 
current DSM-IV-TR diagnosis of manic episode or psychosis were excluded because the 
presence of a thought disorder would have made it difficult for the participant to engage in a 
lengthy neuropsychological assessment.  Participants with a current diagnosis of Attention-
Deficit/Hyperactivity Disorder (ADHD) were also excluded, as research has shown that the co-
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occurrence of ADHD with depression is associated with additional cognitive impairment above 
that seen in depression alone (Larochette, Harrison, Rosenblum, & Bowie, 2011).  Inclusion of 
such individuals would have invalidated the findings, as the presence of psychotic features or 
mania, and attentional difficulties associated with ADHD can influence the manifestation of 
cognitive impairment in depressive disorders (Bakkour et al., 2014; Mohanty & Heller, 2002).  
Out of the 108 individuals who took part in the study, 28 were excluded for various 
reasons.  Twenty individuals were excluded from the depressed group and one individual was 
excluded from the control group because they met criteria for ADHD, four individuals did not 
meet inclusionary or exclusionary criteria (two due to age and two met criteria for current 
psychosis), and three individuals had a significant amount of incomplete data (greater than 5% of 
scale or subscale items).  This resulted in a final study sample of 74 individuals (47 women, 27 
men).   
Sample characteristics.  The mean age of the study sample was 29.01 years (SD = 
14.68).  Over half of individuals were on current medication (55.4%) and the majority of the 
sample was right-handed (90.5%).  The majority of the sample identified their relationship status 
as single (56.8%), with 75.7% reporting that their highest degree completed being a high school 
diploma, and about one-fifth (20.3%) reporting that their annual family income to be $100, 000 
or greater.  The majority of the sample identified as either Caucasian (39.2%), with a smaller 
percentage identifying as Asian (36.5%).  In terms of religion, 27.0% identified as ‘Other’, 
14.9% identified as Protestant, and 12.9% as Hindu.  For a complete summary of the 
demographic characteristics of the sample, please see Table 1. 
It was also observed that 59.2% of individuals in the sample met criteria for a past major 
depressive episode, with 22.4% meeting criteria for a current major depressive episode, and 
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39.5% meeting criteria for major depressive disorder.  Many of the individuals in the depressed 
group also met criteria for one or more anxiety disorders, the most common of which was 
generalized anxiety disorder (39.5%), followed by panic disorder lifetime (22.4%), and 
generalized social phobia (21.1%).  See Table 2 for the complete diagnostic findings from the 
structured clinical interview using the MINI. 
Group classification.  Individuals in the depressed group met DSM-IV-TR criteria for 
current or past MDE or MDD.  Incentive for participation for this group was free 
neuropsychological testing at the START Clinic, for which they would have paid otherwise.  The 
control group consisted of nondepressed university students with no history of depression.  They 
were offered course credit for their participation. 
The total sample was divided into depressed and control groups.  Within the depressed 
group, 31 individuals were recruited from the Start Clinic and 14 were recruited from UTSC.  
For the control group, all 29 individuals were recruited from UTSC.  Incentive for participation 
for those individuals recruited from the START clinic was free neuropsychological testing, 
which they would have paid for otherwise.  Individuals recruited from UTSC were offered 
course credit for their participation.  Since the individuals in the depressed group came from 
different sites, they were examined separately for demographic characteristics.  Table 1 shows 
the demographic characteristics and Table 2 displays information on the psychiatric diagnoses 
for each group and for the total sample. 
START depressed group.  A total of 31 individuals were included in the START 
depressed group (16 women, 15 men).  The mean age of the sample was 42.35 years (SD = 
13.45).  The majority of individuals was on current medication (93.5%) and was right-handed 
(90.3%).  Almost all identified their relationship status as dating (96.8%), almost half (48.4%) 
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reported that their highest degree completed was a high school diploma, and about one-third 
(35.5%) of the sample reported their annual family income to be $100, 000 or greater.  
Approximately three-quarters of the sample identified as Caucasian (74.2%).  In terms of 
religion, 29.0% chose not to identify and 25.8% identified as ‘Other’.  
All 31 (100%) of the individuals in the START depressed group met criteria for major 
depressive episode past, with 35.5% meeting criteria for a current major depressive episode, and 
64.5% meeting criteria for major depressive disorder.  Many of the individuals in the depressed 
group also met criteria for one or more anxiety disorders, the most common of which was 
generalized anxiety disorder (80.6%), followed by generalized and non-generalized social phobia 
(58.1%), panic disorder lifetime (48.4%), and agoraphobia (35.5%).   
UTSC depressed group.  A total of 14 individuals were included in the UTSC depressed 
group.  The mean age of the sample was 18.64 years (SD = 1.78).  Half of the sample was on 
current medication (50.0%) and 92.9% were right-handed.  The majority of the sample identified 
their relationship status as single (75.9%) and almost all (93.1%) individuals reported that their 
highest level of education was a high school diploma or GED.  Almost one-third (28.6%) of the 
sample reported that they did not know their annual family income, with 21.4% reporting an 
annual family income between $16,000 and $24,999 and 21.4% over $100,000.  Over half of the 
sample identified as Asian (57.1%) and close to half (42.9%) of the sample identified their 
religion as Hindu.  
All 31 (100%) of the individuals in the UTSC depressed group met criteria for major 
depressive episode past, with 42.9% meeting criteria for a current major depressive episode, and 
71.4% meeting criteria for major depressive disorder.  Many of the individuals in the UTSC 
depressed group also met criteria for one or more anxiety disorders, the most common of which 
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was generalized anxiety disorder (35.7%), followed by post-traumatic stress disorder (21.4%), 
and panic disorder limited symptoms (21.4%).  
Control group.  A total of 29 individuals were included in the control group (20 women, 
9 men).  The mean age of the sample was 19.76 years (SD = 5.22).  A small portion of 
individuals was on current medication (17.5%) and the majority of the sample was right-handed 
(89.7%).  The majority of the sample identified their relationship status as single (75.9%) and 
almost all (93.1%) individuals reported that their highest level of education was a high school 
diploma or GED.  Over half (58.6%) of the sample reported that they did not know their annual 
family income and 48.3% identified as Asian (48.3%).  In terms of religion, one-third (31.0%) of 
the sample identified as ‘Other’, 20.7% identified as Protestant, and 20.7% identified as Muslim.   
For individuals in the control group, 6.9% met criteria for substance abuse, 3.4% for 
panic disorder lifetime, 3.4% for obsessive compulsive disorder, 3.4% for alcohol dependence, 
and 3.4% for alcohol abuse.  No individuals from either depressed groups or the control group 
met criteria for bipolar NOS, a psychotic disorder, an eating disorder, or ADHD.   
Measures 
Mini International Neuropsychiatric Interview (M.I.N.I.).  The MINI (Sheehan et al., 
1998) is a short, semi–structured diagnostic inventory intended to explore 17 disorders based 
upon the Diagnostic and Statistical Manual for Mental Disorders, fourth edition (DSM-IV-TR, 
American Psychological Association, 2000).  It consists of standardized, structured, closed-end 
questions throughout its diagnostic procedure.  Psychiatric diagnosis is made according to the 
number of affirmative replies to the specific questions.  The MINI has demonstrated excellent 
inter-rater and test-retest reliabilities (Sheehan et al., 1998) and good convergent validity relative 
to the Structured Clinical Interview for Diagnostic and Statistical Manual (SCID) (Sheehan et al., 
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1997).  For the purpose of the current study, an extended version of the MINI (MINI-Plus) was 
used to describe the sample and establish diagnoses, as it covers a larger time frame (including 
current and lifetime diagnoses; see Appendix D).   
Neuropsychological Assessment Battery Screening Module (S-NAB). The 
Neuropsychological Assessment Battery (NAB; Stern & White, 2003) is used in the current 
study to assess objective psychometric neuropsychological test performance.  The NAB is a 
comprehensive battery of tests comprised of the following domain-specific modules: screening, 
attention, language, memory, visuospatial, and executive functioning.  The first module, the 
Screening Module (S-NAB), is an abbreviated version of the full NAB.  The S-NAB consists of 
14 brief individual tests, which yield five index scores reflecting the five cognitive domains 
assessed by the full version of the NAB.  The domains (and individual tests) of the S-NAB are 
listed below:  
1. Attention  (Orientation, Digits Forward, Digits Backward, Numbers & Letters Efficiency-
Part A and Part B) 
2. Language  (Auditory Comprehension and Naming) 
3. Memory  (Shape Learning Immediate Recognition, Shape Learning Delayed 
Recognition, Story Learning Immediate Recall, and Story Learning Delayed Recall) 
4. Spatial (Visual Discrimination and Design Construction) 
5. Executive Functioning  (Mazes and Word Generation) 
The Screening Module takes less than one hour to administer.  The Screening Module 
yields standardized scores similar to IQ scores (M = 100, SD = 15) for the five indexes.  The 
primary test scores are represented as T-scores (M = 50, SD = 10).  There are two parallel forms 
(Form 1 and Form 2) for each of the domain modules.  Only Form 1 was used because Form 2 
ASSESSING COGNITIVE FUNCTIONING IN DEPRESSION  
 
31 
was reserved to reassess participants if the first NAB administration using Form 1 was invalid.  
The T-scores were used as the primary measure of objective psychometric neuropsychological 
test performance in the present study.  Higher T-scores indicated better cognitive functioning. 
Internal consistency of the five domains assessed in the S-NAB range from .24 to .79 and 
test-retest reliabilities range from .11 to .71.  Cronbach’s alpha for the whole S-NAB was found 
to be .60 (Zgaljardic & Temple, 2010). The S-NAB has also been found to display good 
construct validity and discriminative ability (Grohman & William Fals-Stewart, 2004; Zgaljardic 
& Temple, 2010).   
Patient Health Questionnaire (PHQ-9; see Appendix E).  The PHQ-9 (Kroenke, 
Spitzer, & Williams, 2001) is a brief self-report instrument designed to assess depression.  
Although it can be used to establish provisional MDD diagnoses, it is used in the present study to 
assess the severity of depressive symptoms.  The PHQ-9 consists of nine items, each of which 
maps onto the nine DSM-IV criteria for MDD.  Patients indicate how much they have been 
bothered by the nine symptoms over the past two weeks by responding to a scale that ranges 
from 0 (“not at all”) to 3 (“nearly every day”).  The cut-off scores for severity levels of 
depressive symptoms are as follows: no depression (0-4), mild depression (5-9), moderate 
depression (10-14), moderately severe depression (15-19), and severe depression (20-27). 
Test sensitivity for the PHQ-9 ranges from 68%-95%, while the test specificity ranges 
from 84%-95% for MDD.  The positive predictive value of the PHQ-9 ranges from 31% to 51% 
depending on the cut-off value and is similar to those of other instruments.  Internal consistency 
estimates of the PHQ-9 range from .83 to .92 (Cameron, Crawford, Lawton & Reid, 2008).  The 
PHQ-9 was used in the present study to measure the severity of depressive symptoms in the 
depressed and control groups. 
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There are a number of reasons for using the PHQ-9 instead of the Beck Depression 
Inventory (BDI-II) and the Hamilton Rating Scale for Depression (HAM-D), both of which are 
often cited as the gold standard measure of depression severity.  The PHQ-9 has been shown to 
demonstrate psychometric properties similar to that of the BDI-II, but because it is both shorter 
and based directly on the DSM-IV diagnostic criteria of depression, it has an advantage over the 
BDI-II (Titov et al., 2011).  A review on the use of the HAM-D (Bagby, Ryder, Schuller, & 
Marshall, 2005) found that the HAM-D’s internal reliability is adequate, but many scale items 
are poor contributors to the measurement of depression severity, while others have poor 
interrater and retest reliability.  Furthermore content validity was found to be poor and 
convergent validity and discriminant validity were found to be adequate.  The authors argue that 
it may be time to embrace a new gold standard. In addition to its psychometric limitations, the 
HAM-D also requires 15 to 30 minutes of clinician time to administer and is therefore not 
feasible in many practice settings.  Furthermore, it can be difficult to score and requires 
significant training to obtain inter-rater agreement.  
Generalized Anxiety Disorder Scale (GAD-7; see Appendix F).  The Generalized 
Anxiety Scale (GAD-7) (Spitzer, Kroenke, Williams, & Lowe, 2006) is a brief, 7-item self-report 
measure to assess the severity of anxiety symptoms.  Individuals are asked to rate their 
symptoms over the past two weeks on a 4-point Likert-type scale ranging from 0 (“not at all”) to 
3 (“nearly every day”). There is also a final question assessing functional impairment of the 
symptoms endorsed by the individual. The maximum score for the GAD-7 is 21 with higher 
scores indicating more severe anxiety symptoms.  The GAD-7 was used in the present study to 
measure anxiety symptoms in both the depressed and control groups. 
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The GAD-7 has displayed excellent internal consistency (Cronbach α = .92) and good 
test-retest reliability (intraclass correlation = .83). The GAD-7 has also displayed good construct 
validity, with higher scores more strongly associated with greater functional impairment.  
Although the comorbidity between Generalized Anxiety Disorder (GAD) and depression is high, 
factor analysis on the GAD-7 confirmed them as distinct dimensions.  There was also good 
agreement between self-report and interviewer-administered versions of the scale (Spitzer et al., 
2006).  The GAD-7 has been shown to demonstrate psychometric properties similar to that of the 
Hamilton Rating Scale for Anxiety (HAM-A) (Kummer, Cardoso, & Teixeira, 2010), but its 
brevity indicates its advantage over the HAM-A.  
Perceived Deficits Questionnaire (PDQ; see Appendix G).  The Perceived Deficits 
Questionnaire (PDQ; Sullivan, Edgley, & Dehoux, 1999) is a 20-item self-report scale used in 
the present study to measure subjective self-reported cognitive functioning.  It assesses perceived 
cognitive deficits in several domains of cognitive functioning that have been found to be 
compromised in multiple sclerosis (MS): prospective memory, retrospective memory, 
attention/concentration, and planning/organization.  Individuals indicate how often they have 
experienced such difficulties during the previous four weeks.  Each of the 20 items is scored on a 
5-point Likert scale  (0 = never, 1 = rarely, 2 = sometimes, 3 = often, 4 = almost always).  The 
total score for the PDQ is calculated by taking the sum of the raw scores for each of the 20 items.  
Total scores range from 0 to 80, with higher scores indicating greater cognitive impairment.  The 
PDQ also generates scores for each of the four subscales.  Subscale scores range from 0 to 20 
and are generated by calculating the sum of the raw scores of specific sets of items as follows: 
attention/concentration (items 1, 5, 9, 13, 17), retrospective memory (items 2, 6, 10, 14, 18), 
prospective memory (items 3, 7, 11, 15, 19), and planning/organization (items 4, 8, 12, 16, 20).   
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Marrie, Miller, Chelune, and Cohen (2003) found that the PDQ demonstrated acceptable 
test-retest reliability when re-administered one to four weeks after initial administration, with 
test-retest reliability coefficient of .85 in a cognitively unimpaired MS sample and .84 in a 
cognitively impaired MS sample. The PDQ has demonstrated good internal consistency.  
Cronbach’s alpha for the cognitively unimpaired MS sample was .93 and alpha for the 
cognitively impaired MS sample was .95.  Sullivan et al. (1999) reported that the full-length 
version of the PDQ has a Cronbach’s alpha of .93.  
The PDQ has also been found to differentiate between levels of depression; PDQ scores 
for severely depressed individuals has been found to be significantly higher than PDQ scores for 
nondepressed controls on all four subscales (Lawrence, Roy, Harikrishnan, Yu, & Dabbous, 
2013). The PDQ was used to measure subjective self-reported cognitive functioning in both the 
depressed and control groups.  Since the PDQ does not assess the cognitive domains of language 
and visuospatial functioning, the PCIQ (see below) was used to cover the full range of cognitive 
functioning. 
Perceived Cognitive Impairment Questionnaire (PCIQ; see Appendix H).  The 
Perceived Cognitive Impairment Questionnaire (PCIQ) was developed by the investigator for the 
purposes of this study and was designed specifically to be a subjective self-report measure that 
corresponds to the S-NAB in the assessment of five cognitive domains: attention, memory, 
language, visuospatial, and executive functioning.  The PCIQ was created by adapting questions 
from an Alzheimer’s screening questionnaire (Masellis & Black, 2008) that assesses attention, 
memory, language, visuospatial problems, judgment, praxis, mood, personality and behaviour, 
and daily functioning.  Only questions that pertained directly to the cognitive domains of interest 
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were used and were modified to be similar in structure as questions on the Perceived Deficits 
Questionnaire (PDQ).   
The PCIQ is a 17-item self-report scale that measures five areas of cognition: attention, 
memory, visuospatial, language, and executive functioning.  Individuals answer how often they 
have experienced such difficulties during the previous four weeks. Scores for each of the 17 
items of the PCIQ is scored on a 5-point Likert-type scale (0 = never, 1 = rarely, 2 = sometimes, 
3 = often, 4 = almost always).  The total score for the PCIQ is calculated by taking the sum of the 
raw scores for each of the 17 items.  Total scores range from 0 to 68, with higher scores 
indicating greater cognitive impairment.  The PCIQ was used in addition to the PDQ, since it 
covers additional areas, as a measure of subjective self-reported cognitive functioning.  Where 
there is an overlap in the cognitive domains (attention, memory, executive functioning) covered 
by both PDQ and PCIQ, the PDQ was considered to be the primary measure for these domains 
because it is a more established scale.  Since the PDQ does not measure the full range of 
cognitive domains assessed by the S-NAB, specifically the domains of language and visuospatial 
functioning, the PCIQ was created as a supplementary measure to address these domains.   
Sheehan Disability Scale (SDS; see Appendix I).  The Sheehan Disability Scale (SDS) 
is a three-item self-report scale assessing the impact of symptomology on functional impairment 
(Sheehan, 1983) in three domains: work, social and family.  Responses are scored on an 11-point 
scale having response options labeled none (0), mild (1-3), moderate (4-6), severe (7-9), and very 
severe (10).  The scale generates four scores: a work disability score, a social life disability 
score, a family life disability score, and a total score.  A total score is derived by adding up the 
other three individual scores (work, social life, family life).  The maximum possible score is 30 
where higher scores indicate more severe functional impairment.  The SDS has high internal 
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consistency reliability (α  = 0.89) and construct validity (Leon, Olfson, Portera, Farber, Sheehan, 
1997).  The SDS also displays high discriminative validity, as patients with major depression or 
panic disorder have been found to score higher on the SDS than patients with chronic medical 
conditions or with no chronic pathology.  Furthermore, a cut-off score of 8 in the SDS has been 
found to adequately discriminate between patients with and without depression, with a sensitivity 
of 82% and a specificity of 71% (Luciano et al., 2010).  The total score on the SDS was used to 
establish functional impairment in both the depressed and control groups.   
Procedure 
Patients at the START Clinic were informed about the present study.  Those who 
expressed interest were scheduled for individual appointments by the current investigator.  The 
standard consent form that they completed for assessment at the clinic (see Appendix J) served 
as the research consent form; the standard form covers consent for assessment data to be part of 
on-going research efforts at the clinic.  At the UTSC site, introductory psychology students 
logged onto a website that listed various studies that students could participate for course credit.  
The description for this study indicated that students would undergo performance-based 
neuropsychological tasks and complete self-report measures looking at cognition, mental health, 
and functional impairment.  The description also indicated that the experiment would take a 
maximum of three hours and that students would be credited with three points for their 
participation.  Those students who were interested were able to sign up for individual 
appointments at the lab.       
Part 1.  Part 1 included an introduction and overview of the research study to potential 
participants, followed by a review of the consent form (see Appendix J and K, respectively, for 
START Clinic and UTSC participants).  Participants were informed that they would be engaging 
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in a number of game-like tasks meant to tap functions such as attention, memory, concentration, 
and other mental abilities.  They were also told that some of the tasks were simple, while others 
were more difficult and may cause some frustration.  Finally participants were told that they 
would be timed on certain tasks, but that they should ignore this and just try their best.  If the 
participant felt comfortable with the study protocol and signed the consent form, the objective 
neuropsychological test (S-NAB) was completed.  The S-NAB was completed before the 
structured clinical interview in order to reduce any effects of the MINI on the performance on the 
NAB. 
Part 2.  In Part 2, the structured clinical interview (MINI-Plus) was completed.  The 
results were used to establish diagnoses and for classification of participants into the depressed 
and control groups. 
Part 3.  In Part 3, a medical and socio-demographic questionnaire (see Appendix M and 
N, respectively) was given to each participant, followed by a questionnaire package consisting of 
self-report measures.  The measures in the package included the Patient Health Questionnaire 
(PHQ)-9, the Perceived Deficits Questionnaire (PDQ), the Perceived Cognitive Impairment 
Questionnaire (PCIQ), and the Sheehan Disability Scale (SDS).  The order of the self-report 
measures was counterbalanced across participants such that any measure that was presented first 
to a participant would be re-sequenced to the bottom of the pile of measures for the next 
participant. 
Part 4.  Part 4 took place immediately after the participants filled out all the 
questionnaires.  The participants at the START Clinic were debriefed by Dr. Katzman and 
provided with treatment where needed.  The participants from the UTSC site were debriefed 
verbally by the current investigator (see Appendix O).  Those who had significant psychological 
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Missing data.  The data was entered into the Statistical Package for the Social Sciences 
(SPSS) and was screened for missing items.  For participants with a small number (less than 5%) 
of missing scale or subscale items, each missing item was replaced with the mean value for that 
particular group on that item (Tabachnick & Fidell, 2007).  
Univariate and multivariate outliers.  The data was also screened for univariate and 
multivariate outliers.  Within group univariate outliers are cases within each group with extreme 
values on one variable that can distort results (Tabachnick & Fidell, 2007).  To screen for 
univariate outliers, scores on all scale items were standardized into z-scores in SPSS. Once 
transformed, any cases with a z-score that exceeded ±3.29 were identified as univariate outliers 
(Tabachnick & Fidell, 2007).  Each raw score for the outlier was moved to a raw score that was 
within plus or minus three standard deviations of the mean. This would make the case extreme 
with respect to the group that it is in, but would not have undue influence on the overall results.  
Multivariate outliers are cases with unusual combinations of scores on two or more 
variables that can distort results (Tabachnick & Fidell, 2007).  Multivariate outliers were 
assessed using Mahalanobis’ distance and Cook’s D.  The Mahalanobis distance measures the 
distance between a case and its distribution.  Cook's D measures the combined influence of a 
case being an outlier on y and on a set of predictors (Stevens, 2002).  Influential outliers were 
defined as those with a Mahalanobis distance with χ
2
 value that was significant at p ˂ .001 and a 
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Cook’s D that exceeded the value of one (Stevens, 2002).  Using this method, no multivariate 
outliers were identified. 
Multicollinearity.  Analysis of the correlations among all variables for the total sample 
was conducted to test for multicollinearity (see Table 3 for the complete correlation matrix).  
Multicollinearity is present if two or more variables are highly correlated with one another (r = 
.90 or greater), which can cause redundancy (Tabachnick & Fidell, 2007).  In the present 
analysis, correlations between subscales ranged from ranged from r = -.27 to r = .75.  As there 
were no variables that reached the cut-off value of r = .90, multicollinearity was not present.   
Further examination revealed that a number of variables were significantly correlated.  
The subjective measures were correlated with the functional impairment measures and ranged 
from .05 to .63.  Severity of depression was significantly correlated with the objective language 
(r = -.25, p < .05) and visuospatial (r = -.24, p < .05) modules.  Severity of depression was also 
significantly correlated with all subjective cognitive measures as well as all functional 
impairment subscales.  The objective cognitive measures were not significantly correlated with 
any of the subjective cognitive measures or any of the functional impairment measures.   
Comparison of groups.  Analyses were undertaken to determine whether the UTSC 
depressed group and the START depressed group should be pooled together into one large 
depressed group.  A one-way analysis of variance (ANOVA) revealed significant differences 
between the groups on severity of depression, F(2, 71) = 4.20, p = .02.  Post hoc analyses using 
Tukey’s honestly significant difference (HSD) revealed that the UTSC depressed group (M = 
13.14, SD = 5.33) was more severely depressed than the control group (M = 7.10, SD = 5.87), p 
= .01, d = 1.08, but that there was no significant difference between the START depressed group 
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(M = 9.13, SD = 7.25) and the control group (M = 7.10, SD = 5.87), p = .44, d = 0.31, or between 
the two depressed groups, p = .13, d = 0.63.  
Using a one-way ANOVA, significant differences were also found between the groups on 
age, F(2, 71) = 54.14, p = .00.  Post hoc analyses using Tukey’s HSD revealed that there was a 
significant difference between the START depressed (M = 42.35 years, SD = 13.45) and UTSC 
depressed groups (M = 18.64, SD = 1.78), p = .00, d = 2.47, and between the START depressed 
(M = 42.35 years, SD = 13.45) and control groups (M = 19.76 years, SD = 5.22), p = .00, d = 
2.21.  Based on Cohen’s (1988) recommendations, the effect size between the groups can be 
considered large, further supporting the difference between the groups.  No significant 
differences were found between the UTSC depressed and control groups, p = .93, d = 0.29.  This 
result is not surprising, as both groups consisted of university students who were recruited from 
UTSC. 
Differences between the three groups were also compared for gender.  A chi-square test 
found no significant difference between the groups, χ
2
 (2, N = 74) = 3.64, p = .16.  Thus, the 
groups did not differ with respect to gender.   
Since no significant differences were found between the START and UTSC depressed 
groups on severity of depression or gender, they were combined into one depressed group.  An 
ANOVA was carried out to determine whether the combined depressed group and the control 
group differed on severity of depression.  The results showed that the groups significantly on 
severity of depression, F(1, 72) = 4.44, p = 0.39, with the combined depressed group (M = 10.38, 
SD = 6.91) reporting more severe depressive symptoms than the control group (M = 7.10, SD = 
5.87). 
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Anxiety.  Anxiety is often found among individuals with depression (Lamers et al., 2011) 
and can interfere with test performance (Airaksinen, Larsson, & Forsell, 2005; Snyder, 2013), 
and influence self-report (Eysenck, 1997).  Thus, the effects of anxiety may unduly influence the 
dependent variables.  The effects of anxiety can be statistically controlled in covariate analysis.  
However, two criteria must be met: 1) the groups must differ on anxiety and 2) anxiety must be 
related to the dependent variables. 
To determine if the depressed and control groups differed with respect to anxiety, a one-
way ANOVA was conducted.  A significant difference was found between the groups on 
anxiety, F(1, 71) = 12.11, p = .001, d = 0.85, with the depressed group (M = 10.07, SD = 6.77) 
having significantly higher anxiety than the control group (M = 4.97, SD = 5.04).  Based on 
Cohen’s (1988) recommendations, the effect size between the groups can be considered large, 
further supporting the difference between the groups. 
 To determine whether anxiety was related to the dependent variables, bivariate 
correlation analyses were carried out.  It was found that anxiety was significantly correlated with 
the subjective subscales of attention (r = .49, p < .01), memory (r = .39, p < .01), and executive 
functioning (r = .45, p < .01).  It was also significantly correlated with functional impairment in 
the domains associated with work (r = .50, p < .01), family (r = .51, p < .01), and social life (r = 
.54, p < .01).  No other significant correlations were observed. 
Given that the two aforementioned criteria were met only for the subjective self-report of 
cognitive functioning and impairment variables, anxiety was used as a covariate in the analyses 
involving these variables.  Anxiety was not partialled out in analyses involving the objective 
psychometric neuropsychological test measures. 
 




 Table 4 presents the mean and standard deviation of all dependent variables by group and 
total sample.  Table 5 displays correlations among all the dependent variables for the depressed 
group only. 
Group differences on objective psychometric neuropsychological test measures.  A 
multivariate analysis of variance (MANOVA) was conducted to determine group differences on 
objective psychometric neuropsychological test measures in the domains of attention, memory, 
language, visuospatial functioning, and executing functioning.  Using this method, a statistically 
significant difference was found, F(5, 68) = 2.76, p = .025, Wilk’s λ = .83, partial η
2
 = .17.  
Follow-up tests revealed that there was a significant group difference on the objective executive 
functioning subscale, F(1, 72) = 6.48, p = .01, partial η
2
 = .17, d = 0.60, with the control (M = 
89.41, SD = 15.52) group performing significantly worse than the depressed group (M = 98.33, 
SD = 14.17).   
Group differences on subjective self-report of cognitive functioning.  A multivariate 
analysis of covariance (MANCOVA) was conducted to determine the group differences on 
subjective self-report of cognitive functioning in the domains of attention, memory, language, 
visuospatial functioning, and executing functioning, with anxiety as the covariate. Using this 
method, a statistically significant difference was found, F(5, 67) = 5.88, p = .00, Wilk’s λ = .70, 
partial η
2
 = .31.  Follow-up tests revealed that there was a significant group difference on the 
subjective visuospatial subscale, F(1, 72) = 8.74, p = .00, partial η
2
 = .11, d = 0.54 with the 
depressed group (M = 3.09, SD = 2.73) reporting significantly fewer visuospatial functioning 
deficits than the control group (M = 4.52, SD = 2.52).  
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Group differences ups on functional impairment.  A MANCOVA was also conducted 
to determine group differences on functional impairment in the domains of work, social, and 
family, with anxiety as the covariate.  Using this method, a statistically significant difference was 
found, F(3, 69) = 6.25, p = .00, Wilk’s λ = .79, partial η
2
 = .21.  Follow-up tests revealed that 
there was a significant group difference on all three of the subscales, with the depressed group 
reporting greater functional impairment than the control group in work, F(1, 71) = 7.84, p = .01, 
partial η
2
 = .10, d = 1.04, social, F(1, 71) = 15.21, p = .00, partial η
2
 = .18, d = 1.31, and family, 
F(1, 71) = 14.24, p = .00, partial η
2
 = .17, d = 1.31, domains (see Table 4 for group means). 
Depressed group:  Relationship between severity of depression and cognitive 
measures.  Bivariate correlation analyses were conducted to determine the relationship between 
severity of depression, and both the objective psychometric neuropsychological test measures 
and subjective self-report of cognitive functioning in the depressed group (see Table 5).  There 
was a significant correlation between the PHQ-9 and the following subjective domains: attention 
(r = .46, p < .01), memory (r = .40, p < .01), executive functioning (r = .47, p < .01), and 
language (r = .45, p < .01).  No other significant correlations were found.  
Depressed group:  Relationship between severity of depression and functional 
impairment.  There were significant correlations between the severity of depression and 
functional impairment in domains associated with work (r = .42, p < .01), social (r = .43, p < 
.01), and family (r = .55, p < .01). 
 Depressed group:  Relationship between cognitive measures.  Bivariate correlation 
analyses were conducted to determine the relationship between objective psychometric 
neuropsychological test measures and subjective self-report of cognitive functioning in the 
domains of attention, language, memory, visuospatial functioning, and executive functioning 
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(see Table 5).  Only three significant relationships were found: objective attention and subjective 
attention (r = -.44, p < .01), objective executive functioning and subjective executive functioning 
(r = -.30, p < .05), and objective executive functioning and subjective attention.   
Depressed group:  Relationship between objective psychometric neuropsychological 
test measures and functional impairment.  Correlational analyses were conducted to determine 
the relationship between objective psychometric neuropsychological test measures (attention, 
language, memory, visuospatial functioning, executive functioning) and functional impairment 
(work, family, social).  As can be seen from Table 5, significant relationships were found 
between objective attention and family functioning (r = -.37, p < .05), objective language and 
work (r = -.35, p < .05), and objective language and social functioning (r = -.30, p < .05). 
Depressed group:  Relationship between subjective self-report of cognitive 
functioning and functional impairment.  Bivariate correlation analyses were conducted to 
determine the relationship between subjective self-report of cognitive functioning (attention, 
language, memory, visuospatial functioning, executive functioning) and functional impairment in 
the three domains (work, social, family).  It was observed that subjective attention, memory, 
executive functioning, and language were all significantly correlated with greater self-reported 
functional impairments in all three domains (see Table 5).   
In the work domain, the highest correlation was found for subjective attention (r = .53, p 
< .01) and the lowest correlation was found for subjective executive functioning (r = .38, p < 
.05).  In the social domain, the highest correlation was found for subjective attention (r = .63, p < 
.01) and the lowest correlation was found for subjective memory (r = .47, p < .01).  In the family 
domain, the highest correlation was found for subjective attention (r = .56, p < .01) and the 
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lowest correlation was found for subjective language (r = .47, p < .01).  No other significant 
correlations were found. 
Discussion 
The objective of the present study was to investigate the concordance between objective 
psychometric neuropsychological test measures and subjective self-report of cognitive 
functioning in depression and its relationship to functional impairment (work, social, family).  
The domains of cognitive functioning that were examined were attention, memory, language, 
visuospatial functioning, and executive functioning.  Seven hypotheses were proposed.  The first 
three addressed differences between the depressed and control groups, and the remaining four 
looked at associations among objective and subjective cognitive measures and functional 
impairment within the depressed group only.   
Findings Regarding Group Differences 
The first hypothesis, which stated that the depressed group would perform more poorly 
than the control group on objective psychometric neuropsychological test measures in the 
domains of attention, memory, visuospatial functioning, and executive functioning, was not 
supported.  Contrary to the hypothesis, the control group was found to perform significantly 
worse than the depressed group on the executive functioning module.  Based on Cohen’s (1988) 
recommendations, analyses also revealed a medium to large effect size between the groups on 
the executive functioning module, further supporting the difference between the groups.  
Furthermore, the results showed that there was no significant difference between the groups in 
the domains of attention, memory, language, or visuospatial functioning. 
These results are not consistent with previous research showing that individuals with 
depression score worse than nondepressed controls on tests of executive functioning (Henry & 
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Crawford, 2005; Naismith et al., 2003; Rogers et al., 2004; Zakzanis et al., 1998).  However, a 
review shows that there have been inconsistent findings in the literature on performance-based 
cognitive deficits in depression (McClintock, Husain, Greer, & Cullum, 2010).  It has been 
postulated that this could be due to differences across studies in sample characteristics and/or in 
methods used to assess cognitive dysfunction (Burt et al., 1995; Zakzanis et al., 1998).   
In the present study, the screening module of the S-NAB was employed to measure 
objective performance-based cognitive functioning.  The screening module is normally used to 
identify individuals who may benefit from further comprehensive neuropsychological 
assessment (Stern & White, 2003).  It is possible that the screening module was not sensitive 
enough to detect cognitive differences between the depressed and control groups.  Additionally, 
the specific characteristics of the samples used in this study may also have contributed to the 
absence of significant findings.  At the time of the study, almost half (42.2%) of the depressed 
group was using psychiatric medication, some of which included selective serotonin reuptake 
inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs), norepinephrine 
dopamine reuptake inhibitors (NDRIs), and atypical antidepressants such as Vorioxetine (see 
Table 6).  These classes of psychiatric medications have all been associated with improved 
cognitive functioning in depression (Greer, Sunderajan, Grannemann, Kurian, & Trivedi, 2011; 
Pehrson et al., 2015; Raskin et al., 2007; Rosenblat, Kakar, & McIntyre, 2015).  Since none of 
the control participants were on psychiatric medications as expected, it is possible that group 
differences were not found on objective cognitive measures due to the effects of psychiatric 
medication. 
The lack of a significant difference between the groups on objective psychometric 
neuropsychological test measures may also be explained by differences in motivation between 
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the two groups.  The control group was recruited entirely from UTSC and were participating for 
the purposes of course credit.  These individuals would have received course credit regardless of 
how much effort they put forth on the S-NAB.  On the other hand, the majority of individuals in 
the depressed group were recruited from the START Clinic; these individuals were participating 
because information gained from the study would inform their treatment planning.  Thus, it is 
possible that the control group may have been less motivated to try their hardest on the S-NAB 
than the depressed group.  Supporting this notion, previous research has found that 
undergraduate university students may put forth suboptimal effort during neuropsychological 
testing (An, Zakzanis, & Joordens, 2012).  This may also explain why the control group 
performed worse than the depressed group on the S-NAB executive functioning module.  
However, this must be interpreted with caution since this effect was only found for the executive 
functioning module of the S-NAB.  
The resource-allocation hypothesis suggests that individuals with depression have a 
reduced cognitive capacity, which leads to deficits in cognitive functioning (Ellis & Ashbrrok, 
1988).  According to this view, individuals with depression allocate a significant amount of their 
attentional resources on ruminations (perseverating self-focused thoughts), a hallmark of 
depression, thereby preventing these resources from being allocated to the cognitive task at hand 
(Gotlib & Joorman, 2010; Levens, Muhtadie, Gotlib, 2009).  In support of this, Hertel (1998) 
found a comparable memory recall deficit between dysphoric students who, between study and 
recall phases, were not given any instructions on what to do during the waiting period 
(unconstrained situation) and dysphoric students who were instructed to rate self-focused 
material designed to induce rumination.  In contrast, no recall deficit was found for dysphoric 
students who were instructed to rate self-irrelevant and task-irrelevant material (constrained 
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condition).  These results suggest that, at least with respect to memory deficits, individuals with 
depression have the ability to perform at the level of their nondepressed counterparts in 
structured/constrained situations but may not be able to function at this level on their own 
initiative in unconstrained situations.  The participants in the present study completed the S-NAB 
under structured conditions, such that there was no point in which they would have had time to 
ruminate during the administration.  Perhaps, completing the S-NAB in a structured environment 
that eliminated the opportunity for rumination to occur also eliminated impairment on the 
cognitive tasks, a result that might explain why there was no difference in objective 
psychometric neuropsychological test performance between the depressed and control groups, 
with the exception of the executive functioning module.  
The second hypothesis, which stated that the depressed group would report greater 
impairment than the control group on subjective self-report of cognitive functioning in the 
domains of attention, memory, and executive functioning, was not supported.  Results showed 
that the depressed and control groups did not differ on self-reported attention, memory or 
executive functioning.  This could again be due to specific sample characteristics.  As noted 
above, most of the individuals in the depressed group were on current medications and this may 
have improved their cognitive functioning.  Another possibility is that these null results are due 
to the use of self-report measures.  Self-report are subject to the influence of social desirability 
(Murphy & Davidshofer, 2005).  Possibly, the depressed group did not want to report that they 
were experiencing cognitive difficulties, and could have inflated their self-report of cognitive 
functioning.  However, this is not likely because there is a large body of research to indicate that 
depressed individuals have negative thinking particularly with respect to themselves and are 
more likely to self-report in a negative or pessimistic manner (Joormann et al., 2015).  It is 
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possible that the depressed participants had a frame of reference that was different from the one 
used by the participants in the control group.  If the depressed group had been having depressive 
symptoms for an extended period of time, they might have relied on their usual level of 
functioning (i.e., depressed) as the norm in their self-report, while the nondepressed control 
group could have used their usual euthymic states as the norm.  Consequently, the depressed 
group might have reported their current functioning as no different from the control group 
because the two groups were using different standards of reference. 
Interestingly, a significant difference between the groups was found on the subjective 
visuospatial subscale, with the control group reporting greater visuospatial functioning deficits 
than the depressed group.  Based on Cohen’s (1988) recommendations, analyses also revealed a 
medium effect size between the groups on the executive functioning module, further supporting 
the difference between the groups.  No studies have looked at subjective cognitive complaints 
associated with depression in the visuospatial functioning domain.  This is a novel and 
interesting finding, suggesting that individuals with depression report fewer visuospatial 
cognitive deficits than their nondepressed counterparts.  This effect could be due to the use of the 
PCIQ, which was developed specifically for the purposes of this study.  The PCIQ has not been 
validated and thus the extent to which it accurately measures the domains it purports to measure 
(visuospatial and language) is questionable. 
The third hypotheses stated that the depressed group would report greater functional 
impairment than the control group in work, social, and family domains.  This hypothesis was 
fully supported, as significant group differences were found on all three subscales of the SDS 
(work, social, family), with the depressed group reporting greater functional impairment than the 
control group.  Based on Cohen’s (1988) recommendations, analyses also revealed a large effect 
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size between the groups on all three functional impairment domains, further supporting the 
difference between the groups.  This finding is consistent with previous literature that shows 
depression to be associated with impairment in the social and family domains (Coyne et al., 
2002; Johnson et al., 2000; Kessler & Bromet, 2013; Mickelson, 2001; Nasser & Overholser, 
2005; Windle, 1994), as well as the work domain (Adler et al., 2006; Gilmour and Patten, 2007). 
Severity of Depression  
The fourth hypothesis stated that within the depressed group, greater severity of 
depression symptoms would predict poorer performance in objective psychometric 
neuropsychological test measures in the domains of attention, memory, visuospatial functioning, 
and executive functioning and greater self-rated cognitive dysfunction in the domain of memory.  
This hypothesis was supported only for subjective memory.  This is consistent with previous 
literature that shows that subjective self-reported memory complaints are directly related to the 
presence and severity of depressive symptoms (Naismith et al., 2007).  Severity of depression 
was not related to any of the objective psychometric neuropsychological test measures.  
Although some research has found that severity of depression is associated with objective 
psychometric neuropsychological test measures (e.g. Naismith et al., 2003; Porter et al., 2003), 
contradictory results have also been reported and again have been attributed to variability in the 
samples and methodology used across studies (McDermott & Ebmeier, 2009). 
Other significant relationships were found between severity of depression and subjective 
self-report of attention, executive functioning, and language in the depressed group.  Severity of 
depression was also significantly correlated with all three functional impairment subscales in the 
depression group.  When looking at the total sample (depressed and controls combined), a 
similar pattern emerged: significant relationships were found between severity of depression and 
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all subjective self-report of cognitive functioning as well as all functional impairment domains.  
Overall, these results suggest that individuals with more severe depression are more likely to 
self-report both greater cognitive deficits and functional impairment, but they may not display 
such cognitive deficits on objective psychometric neuropsychological test measures.  This is 
consistent with previous research conducted by Svendsen et al. (2012), who found that severity 
of depression predicted subjective self-report of cognitive functioning but not objective 
psychometric neuropsychological test measures.   
According to Beck’s (1967) theory of depression, individuals with depression have 
negative thoughts about the self, the world, and the future.  Individuals who have more severe 
depression would have more negative thoughts about themselves and may perceive themselves 
as performing more poorly on objective psychometric neuropsychological test measures, hence 
rating themselves as more cognitively impaired.  This perception of cognitive impairment may 
not however be reflective of their actual behaviour on neuropsychological tests, reflected in the 
present study by the null association between the PHQ-9 and the S-NAB.   
Concordance Between Cognitive Measures in Depression 
Hypothesis five, which stated that there would be a positive relationship between 
subjective self-report of cognitive functioning and objective psychometric neuropsychological 
test measures in the domains of attention, memory, and executive functioning in the depressed 
group, was partially supported.  Specifically, poorer objective psychometric neuropsychological 
test performance was significantly associated with greater self-reported cognitive impairment in 
the domains of attention and executive functioning, but not memory.  There was also no 
significant relationship between objective psychometric neuropsychological test measures and 
subjective self-report of cognitive functioning in the domains of memory, language, or 
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visuospatial functioning.  This is the first study to investigate the concordance between objective 
psychometric neuropsychological test measures and subjective self-report of cognitive 
functioning in depression using domains that map directly onto each other.  These results suggest 
that individuals with depression might have greater insight into their functioning in the areas of 
attention and executive functioning and less insight with respect to the remaining areas of 
memory, language, and visuospatial functioning.  Although some authors have postulated that 
the use of self-report with patients with depression is problematic because they are prone to 
cognitive biases in their thinking (Joormann et al., 2015), which can in turn affect their 
subjective reports, it seems that this might not be the case at least in the area of attention and 
executive functioning.  Rather, the results of this study suggest that individuals with depression 
are aware of their objective performance-based cognitive deficits in these two domains and are 
able to accurately report such deficits, as their self-report of cognitive functioning match up with 
how they objectively performed on psychometric neuropsychological test measures.  The 
implication from this finding is that subjective self-report of cognitive functioning could 
potentially be used with individuals with depression in place of more expensive and time-
intensive objective psychometric neuropsychological test measures only in areas associated with 
attention and executive functioning in order to gauge their general level of cognitive functioning.  
However, if the objective of assessment is to establish the precise level of cognitive functioning, 
objective psychometric neuropsychological testing is always required.  This is in part due to the 
fact that using objective psychometric neuropsychological test measures with individuals offers 
important behavioural information that subjective self-report does not. 
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Cognitive Functioning and Functional Impairment in Depression 
Hypothesis six, which stated that poorer performance on objective psychometric 
neuropsychological test measures would predict greater functional impairment associated with 
work within the depressed group, was supported.  The results showed that poorer performance on 
the S-NAB language module was associated with greater impairment in the work and social 
domains, and that poorer performance in the S-NAB attention module was linked to greater 
impairment in the family domain.   
The seventh and final hypothesis, which stated that poorer subjective self-report of 
cognitive functioning would predict greater functional impairment in all domains (work, social, 
family), was also fully supported.  Overall, these results are consistent with previous work 
showing that objective psychometric neuropsychological test measures and subjective self-report 
of cognitive functioning are differentially related to different forms of impairment in depression 
(Naismith et al., 2007). 
The results of this study show that objective language is associated with work impairment 
and objective attention is associated with family impairment.  Subjective self-report of cognitive 
functioning in all five cognitive domains (attention, memory, language, visuospatial functioning, 
executive functioning) were correlated with functional impairment in all domains (work, family, 
social).  Based on these results, it seems that self-report of cognitive functioning may be a better 
predictor of self-reported functional impairment overall, although some objective cognitive 
domains may predict impairment in certain areas of functioning.  
It is possible, however, that the finding that subjective self-report of cognitive impairment 
were a better predictor of functional impairment overall may be due to the fact that the measure 
of functional impairment used (i.e. the SDS) was self-report in nature as well.  It would be 
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expected that individuals who perceive themselves to be cognitively impaired would also 
perceive themselves to be functionally impaired.  However, this perceived impairment might not 
be reflective of actual objective performance-based cognitive deficits. 
Summary  
Overall, when comparing the depressed and control groups, results showed that 
individuals with depression did not differ in either objective psychometric neuropsychological 
test measures or subjective self-report of cognitive functioning.  There were two exceptions to 
this: the control group performed significantly worse on objective executive functioning and self-
reported more visuospatial deficits than the depressed group.  Results also suggest that those 
with depressed tended to report greater functional impairment in all domains than controls.  
However, when looking at depression from dimensional perspective by considering severity of 
depression, rather than looking only at group differences (i.e. depressed and nondepressed), a 
different pattern emerged.  It appears that degree of self-reported impairment was related to 
severity of depression, such that those with more severe depression tended to self-report greater 
cognitive deficits and functional impairment.  Severity of depression was however unrelated to 
objective psychometric neuropsychological test performance. 
When considering the depressed group only, a concordance was found between objective 
psychometric neuropsychological test measures and subjective self-report of cognitive 
functioning in the domains of attention, memory, and executive functioning.  This suggests that 
individuals with depression are aware of their objective performance-based cognitive deficits in 
these domains and are able to accurately report such deficits, as their self-report of cognitive 
functioning match up with how they objectively performed on psychometric neuropsychological 
test measures.   
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Finally, both objective psychometric neuropsychological test measures and subjective 
self-report of cognitive functioning were associated with functional impairment, albeit in 
different domains.  Specifically, cognitive performance in two of the five objective domains was 
predictive of certain domains of functional impairment.  Subjective self-report of cognitive 
functioning in all five domains (attention, memory, language, visuospatial functioning, executive 
functioning) were correlated with self-report of functional impairment in all three domains 
(work, family, social).  Collectively, these results suggest that that subjective self-report of 
cognitive functioning may a better predictor of self-reported functional impairment overall, 
although performance on objective psychometric neuropsychological test measures in certain 
domains may predict impairment in certain areas of self-reported functional impairment.   
Strengths and Limitations 
The results must be viewed within the strengths and limitations of the present study.  
Although there have been a few studies conducted that investigate the relationship between 
objective psychometric neuropsychological test measures and subjective self-report of cognitive 
functioning, none of these studies have used measures with cognitive domains that map directly 
onto each other (Naismith et al., 2007; Svendsen et al., 2011).  Therefore, the extent to which a 
consensus about the concordance between these types of measures in depression can be drawn 
from these results is limited.  Furthermore, no studies have looked at subjective self-reported 
cognitive functioning in visuospatial or executive functioning.  Thus, a strength of the current 
study is that the results provide new information to the area of depression.  Although some 
limitations exist, the present study has implications for future research and for the assessment of 
cognitive functioning in depression.   
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Another strength of the current study is the use of clinical sample.  The majority of the 
depressed group was recruited from a mood and anxiety disorder clinic, which confirms that the 
primary complaint for these individuals was mood-related.  This increases the generalizability of 
the findings from the present study to the depressed population. 
It is also important to consider the limitations of the present study and how they may 
have contributed to the pattern of results.  One limitation of the present study is that medication 
use, particularly antidepressant use, was not controlled for.  Previous research has found that use 
of certain antidepressants is associated with cognitive improvement in depression (Greer et al., 
2011; Pehrson et al., 2015; Raskin et al., 2007; Rosenblat et al., 2015).  Thus, it is possible that 
cognitive impairment in the depressed group may have been improved by medication use, thus 
leading to the null result between the depressed and control group on objective cognitive 
performance, with the exception of the S-NAB executive functioning module. 
Another limitation is that individuals were recruited from different sites, which may have 
led to significant differences between the groups.  Participants from both sites were 
heterogeneous in the duration of their depression, depression severity, chronicity of depression, 
comorbid conditions, and treatment history.  These clinical factors may have influenced their 
degree of cognitive and/or functional impairment (Austin et al. 2001; Baune, McAfoose, Leach, 
Quirk, & Mitchell, 2009; Elgamal, Denburg, Marriott, & MacQueen, 2010). 
A third limitation of the present study is that the PCIQ was developed for the purposes of 
this study and has not been validated or used in other studies.  Thus, the extent to which the 
PCIQ actually measures language and visuospatial functioning is questionable.  The PCIQ was 
developed because no existing self-report measures of language or visuospatial functioning for 
use in depression were identified for use in the present study.  However, the questions used on 
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the PCIQ were developed from an existing questionnaire for Alzheimer’s disease (Masellis & 
Black, 2008).  Furthermore, the questions have high face validity and thus subjectively appear to 
measure the constructs in question. 
Conclusions and Future Directions 
As a whole, the results of this study provide evidence of the concordance between 
objective psychometric neuropsychological test measures and subjective self-report of cognitive 
functioning in depression in the domains of attention, memory, and executive functioning.  The 
results also suggest that subjective self-report of cognitive functioning are a better predictor of 
self-reported functional impairment overall than are objective psychometric neuropsychological 
test measures and that severity of depression is associated with self-report measures of cognitive 
functioning and functional impairment, but not objective tests.  The implication of these results is 
that self-report measures are reliable indicators of one’s objective performance-based cognitive 
functioning in the domains of attention, memory, and executive functioning, and clinicians 
wishing to gauge cognitive functioning in these areas in those with depression may be able forgo 
lengthy and costly objective neuropsychological assessment.  
There were a number of factors that may have affected the results of the present study.  
Particularly, antidepressant use, the presence of comorbid conditions, and the chronicity of 
depression have been found to impact the degree of cognitive impairment in depression (Austin 
et al. 2001; Baune et al., 2009; Elgamal et al., 2010; Pehrson, 2015).  These three variables were 
not controlled for in the present study, thus the extent to which they may have contributed to the 
pattern of results is not known.  Future research should seek to replicate the current research 
while controlling for these variables. 
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The cognitive domains examined in the present study included attention, memory, 
language, visuospatial functioning, and executive functioning.  Others have argued that cognition 
may include other domains, such as motor function, involving psychomotor speed, and social 
cognition, which includes affective and emotional functioning (APA, 2013).  As these domains 
were not specifically examined in the present study, future research should investigate the 
concordance between objective psychometric neuropsychological test measures and subjective 
self-report of cognitive functioning in these areas. 
At the time of the study, there existed no established, validated self-report measures of 
cognitive functioning that directly mapped onto the cognitive domains assessed using the S-
NAB.  As a result, such a measure was created by the investigator for the purposes of the present 
study.  Future research should address this limitation in the literature and results of this study 
should be replicated using a validated self-report measure of cognitive functioning. 
Results of this study showed that subjective self-report of cognitive functioning were a 
better predictor of functional impairment overall than were objective psychometric 
neuropsychological test measures.  It is possible that this effect may be due to the fact that the 
measure of functional impairment used in this study was subjective (i.e. self-report) in nature as 
well, and self-report measures used in depression are often influenced by negative bias (Joorman 
et al., 2015).  Thus, a final suggestion is that future studies should utilize both self-report and 
objective or observer-rated measures of functional impairment in order to determine whether 
objective psychometric neuropsychological test measures or subjective self-report of cognitive 
functioning are better predictors of functional impairment. 
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n = 31 
UTSC depressed 
n = 14 
Depressed combined 
n = 45 
Control 
n = 29 
Total Sample 
n = 74 
Gender      
Female 16 (51.6%) 11 (78.6%) 27 (60.0%) 20 (69.0%) 47 (63.5%) 
Male 15 (48.4%) 3 (21.4%) 18 (40.0%) 9 (31.0%) 27 (36.5%) 
Age (years) 42.36  
(SD = 13.45) 
18.64 
(SD = 1.78) 
34.98 
(SD = 15.73) 
19.76 
(SD = 5.22) 
29.01 
(SD = 14.68) 
Currently on medication 29 (93.5%) 7 (50.0%) 36 (80.0%) 5 (17.2%) 41 (55.4%) 
Handedness      
Right 28 (90.3%) 13 (92.9%) 41 (91.1%) 26 (89.7%) 67 (90.5%) 
Left 2 (6.5%) 1 (7.1%) 3 (6.7%) 2 (6.9%) 5 (6.8%) 
Ambidextrous 1 (3.2%) 0 1 (2.2%) 1 (3.4%) 2 (2.7%) 
Marital status      
Single 9 (29.0%) 11 (78.6%) 20 (44.4%) 22 (75.9%) 42 (56.8%) 
Cohabiting 5 (16.1%) 0 5 (11.1%) 0 5 (6.8%) 
Married 8 (25.8%) 0 8 (17.8%) 1 (3.4%) 9 (12.2%) 
Separated 1 (3.2%) 0 1 (2.2%) 0 1 (1.4%) 
Divorced 2 (6.5%) 0 2 (4.4%) 0 2 (2.7%) 
Dating 5 (16.1%) 3 (21.4%) 8 (17.8%) 6 (20.7%) 14 (18.9%) 
Did not report 1 (3.2%) 0 1 (2.2%) 0 1 (1.4%) 
Highest degree earned      
Less than high school 1 (3.2%)  1 (2.2%)  1 (1.4%) 
High school or GED 15 (48.4%) 14 (100.0%) 29 (64.4%) 27 (93.1%) 56 (75.7%) 
College degree 2 (6.5%)  2 (4.4%)  2 (2.7%) 
Bachelor degree 6 (19.4%)  6 (13.3%) 2 (6.9%) 8 (10.8%) 
Master’s degree 3 (9.7%)  3 (6.7%)  3 (4.1%) 
PhD degree 1 (3.2%)  1 (2.2%)  1 (1.4%) 
Professional degree 1 (3.2%)  1 (2.2%)  1 (1.4%) 
Other 1 (3.2%)  1 (2.2%)  1 (1.4%) 
Did not report 1 (3.2%)  1 (2.2%)  1 (1.4%) 
Annual family income      
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Less than $5,000 1 (3.2%) 0 1 (2.2%) 0 1 (1.4%) 
$5,000-$11,999 2 (6.5%) 0 2 (4.4%) 0 2 (2.7%) 
$16,000-$24,999 1 (3.2%) 3 (21.4%) 4 (8.9%) 1 (3.4%) 5 (6.8%) 
$25,000-$34,999 2 (6.5%) 0 2 (4.4%) 2 (6.9%) 4 (5.4%) 
$35,000-$49,999 3 (9.7%) 2 (14.3%) 5 (11.1%) 2 (6.9%) 7 (9.5%) 
$50,000-$74,999 4 (12.9%) 1 (7.1%) 5 (11.1%) 3 (10.3%) 8 (10.8%) 
$75,000-$99,999 3 (9.7%) 0 3 (6.7%) 2 (96.9%) 5 (6.8%) 
$100,000 or greater 11 (35.5%) 3 (21.4%) 14 (31.1%) 1 (3.4%) 15 (20.3%) 
Don’t know 1 (3.2%) 4 (28.6%) 5 (11.1%) 17 (58.6%) 22 (29.7%) 
No response 3 (9.7%) 1 (7.1%) 4 (8.9%) 1 (3.4%) 5 (6.8%) 
Ethnicity      
Caucasian 23 (74.2%) 2 (14.3%) 25 (55.6%) 4 (13.8%) 29 (39.2%) 
Asian 5 (16.1%) 8 (57.1%) 12 (28.9%) 12 (48.3%) 27 (36.5%) 
African American 1 (3.2%) 0 1 (2.2%) 7 (24.1%) 8 (10.8%) 
Other 1 (3.2%) 4 (28.6%) 5 (11.1%) 4 (13.8%) 9 (12.2%) 
Did not identify 1 (3.2%) 0 1 (2.2%) 0 1 (1.4%) 
Religion      
Protestant 5 (16.1%) 0 5 (11.1%) 6 (20.7) 11 (14.9%) 
Jewish 5 (16.1%) 0 5 (11.1%) 0 5 (6.8%) 
Catholic 4 (12.9%) 2 (14.3%) 6 (13.3%) 2 (6.9%) 8 (10.8%) 
Buddhist 0 0 0 2 (6.9%) 2 (2.7%) 
Hindu 0 6 (42.9%) 6 (13.3%) 3 (10.3%) 9 (12.2%) 
Muslim 0 1 (7.1%) 1 (2.2%) 6 (20.7%) 7 (9.5%) 
Other 8 (25.8%) 3 (21.4%) 11 (24.4%) 9 (31.0%) 20 (27.0%) 
None 9 (29.0%) 0 10 (22.2%) 1 (3.4%) 10 (13.5%) 
Did not report  1 (7.1%) 1 (2.2%)   
 
  












n = 74 
START depressed 
n = 31 
UTSC depressed 
n = 14 
Depressed combined 
n = 45 
Control 
n = 29 
Mood disorders      
Major depressive episode (current) 11 (35.5%) 6 (42.9%) 17 (37.8%) 0 17 (22.4%) 
Major depressive episode (past) 31 (100%) 14 (100%) 45 (100%) 0 45 (59.2%) 
Major depressive episode (recurrent) 25 (80.6%) 9 (64.3%) 34 (75.6%) 0 34 (44.7%) 
Major depressive disorder 20 (64.5%) 10 (71.4%) 30 (66.7%) 0 30 (39.5%) 
Manic episode (current) 0 0 0 0 0 
Manic episode (past) 3 (9.7%) 1 (7.1%) 4 (8.9%) 0 4 (5.3%) 
Manic episode (recurrent) 3 (9.7%) 1 (7.1%) 4 (8.9%) 0 4 (5.3%) 
Hypomanic episode (current) 1 (3.2%) 0 1 (2.2%) 0 1 (1.3%) 
Hypomanic episode (past) 8 (25.8%) 3 (21.4%) 11 (24.4%) 0 11 (14.5%) 
Hypomanic episode recurrent 6 (19.4%) 1 (1.7%) 7 (15.6%) 0 7 (9.2%) 
Hypomanic symptoms (current) 0 0 0 0 0 
Hypomanic symptoms (past) 0 0 0 0 0 
Hypomanic symptoms (recurrent) 0 0 0 0 0 
Bipolar I 3 (9.7%) 1 (7.1%) 4 (8.9%) 0 4 (5.3%) 
Bipolar II 8 (25.8%) 3 (21.4%) 11 (24.4%) 0 11 (14.5%) 
Bipolar NOS 0 0 0 0 0 
Mood disorder + psychotic features 
(lifetime) 
0 0 0 0 0 
Mood disorder + psychotic features 
(current) 
0 0 0 0 0 
Psychotic disorders      
Psychotic disorder (current) 0 0 0 0 0 
Psychotic disorder (lifetime) 0 0 0 0 0 
Anxiety disorders      
Panic disorder (lifetime) 15 (48.4%) 1 (7.1%) 16 (35.6%) 1 (3.4%) 17 (22.4%) 
Panic disorder (current) 3 (9.7%) 0 3 (6.7%) 0 3 (3.9%) 
Panic disorder (limited symptoms) 5 (16.1%) 3 (21.4%) 8 (17.8%) 0 8 (10.5%) 
Agoraphobia (current) 11 (35.5%) 1 (7.1%) 12 (26.7%) 0 12 (15.8%) 
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Social phobia (generalized) 14 (45.2%) 2 (14.3%) 16 (35.6%) 0 16 (21.1%) 
Social phobia (non-generalized) 4 (12.9%) 0 4 (8.9%) 0 4 (5.3%) 
Specific phobia 5 (16.1%) 1 (7.1%) 6 (13.3%) 0 6 (7.9%) 
Obsessive compulsive disorder 6 (19.4%) 1 (7.1%) 7 (15.6%) 1 (3.4%) 8 (10.5) 
Post-traumatic stress disorder 4 (12.9%) 3 (21.4%) 7 (15.6%) 0 7 (9.2%) 
Generalized anxiety disorder 25 (80.6%) 5 (35.7%) 30 (66.7%) 0 30 (39.5%) 
Substance-related disorders      
Alcohol dependence (current) 4 (12.9%) 0 4 (8.9%) 1 (3.4%) 5 (6.6%) 
Alcohol abuse (current) 4 (12.9%) 0 4 (8.9%) 1 (3.4%) 5 (6.6%) 
Substance dependence (current) 3 (9.7%) 0 3 (6.7%) 0 3 (3.9%) 
Substance abuse (current) 3 (9.7%) 0 3 (6.7%) 2 (6.9%) 5 (6.6%) 
Eating disorders      
Anorexia 0 0 0 0 0 
Bulimia 0 0 0 0 0 
Suicidal risk      
Low risk 14 (45.2%) 3 (21.4%) 17 (37.8%) 0 17 (22.4%) 
Moderate risk 2 (6.5%) 0 2 (4.4%) 0 2 (2.6%) 
High risk 1 (3.2%) 0 1 (2.2%) 0 1 (1.3%) 
No risk 14 (45.2%) 11 (78.6%) 25 (55.6%) 29 (100%) 53 (69.7%) 






















Bivariate Correlations Among Variables in the Total Sample (N = 74) 
 
Measure 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1. S-NAB (A) −               
2. S-NAB (L)  .17 −              
3. S-NAB (M)  .32**  .19 −             
4. S-NAB (V)  .35**  .27*  .25* −            
5. S-NAB (EF)  .55**  .30**  .59**  .45** −           
6. PDQ (A) -.30** -.12 -.13 -.22 -.17 −          
7. PDQ (M)  .00  .09  .15 -.01  .04 .69** −         
8. PDQ (EF) -.13 -.01  .02 -.14 -.04 .70** .63** −        
9. PCIQ (L) -.08 -.28* -.02 -.01 -.18 .50** .57** .37** −       
10. PCIQ (V) -.07 -.27* -.00 -.06 -.25* .24* .36** .27** .42** −      
11. SDS (W) -.04 -.25*  .09 -.05  .10 .54** .43** .55** .29*  .05 −     
12. SDS (S) -.11 -.04 -.01 -.12  .05 .63** .51** .53** .31** -.17 .66** −    
13. SDS (F) -.27*  .03 -.03 -.06 -.03 .52** .48** .50** .22 -.15 .61** .75** −   
14. PHQ-9 -.11 -.25* -.10 -.24* -.70 .50** .45** .46** .37** .24* .48** .49** .52** −  
15. GAD-7 -.16 -.07 -.11 -.15  .03 .49** .39** .45** .17 .12 .50** .51** .54** .77** − 
Note. S-NAB (A) = Neuropsychological Assessment Battery Screening module attention subscale; S-NAB (L) = Neuropsychological Assessment 
Battery Screening module language subscale; S-NAB (M) = Neuropsychological Assessment Battery Screening module memory subscale; S-NAB 
(V) = Neuropsychological Assessment Battery Screening module visuospatial subscale; S-NAB (EF) = Neuropsychological Assessment Battery 
Screening module executive functioning subscale; PDQ (A) = Perceived Deficits Questionnaire attention subscale; PDQ (M) = Perceived Deficits 
Questionnaire memory subscale; PDQ (EF) = Perceived Deficits Questionnaire executive functioning subscale; PCIQ (L) = Perceived Cognitive 
Impairment Questionnaire language subscale; PCIQ (V) = Perceived Cognitive Impairment Questionnaire visuospatial subscale; SDS (W) = 
Sheehan Disability Scale work subscale; SDS (S) = Sheehan Disability Scale social subscale; SDS (F) = Sheehan Disability Scale family subscale; 
PHQ-9 = Patient Health Questionnaire; GAD-7 = Generalized Anxiety Disorder Scale. 
*p < .05.   
**p < .01.  












n = 74 
Depressed 
n = 45 
Control 
n = 29 
Objective cognitive    
S-NAB attention 95.20 (17.91) 95.00 (17.22) 95.12 (17.53) 
S-NAB language 112.84 (13.27) 106.90 (25.79) 110.51 (19.23) 
S-NAB memory 93.53 (11.38) 91.17 (13.25) 92.61 (12.11) 
S-NAB visuospatial 104.58 (14.56) 106.03 (12.82) 105.15 (13.83) 
S-NAB executive functioning 98.33 (14.17) 89.41 (15.52) 94.84 (15.25) 
Subjective cognitive    
PDQ attention 10.31 (4.45) 7.66 (2.72) 9.27 (4.06) 
PDQ memory 7.74 (3.77) 5.28 (2.97) 3.88 (2.23) 
PDQ executive functioning 10.40 (4.20) 7.59 (2.92) 9.30 (3.98) 
PCIQ language 3.73 (2.32) 4.10 (2.09) 3.88 (2.23) 
PCIQ visuospatial 3.09 (2.73) 4.52 (2.52) 3.65 (2.72) 
Functional impairment    
SDS work 4.42 (3.20) 1.66 (1.95) 3.34 (3.08) 
SDS social 5.51 (3.13) 2.00 (2.16) 4.14 (3.27) 
SDS family 4.56 (2.85) 1.52 (1.64) 3.36 (2.86) 
PHQ-9 10.38 (6.91) 7.10 (5.87) 9.09 (6.68) 
GAD-7 10.07 (6.77) 4.97 (5.04) 8.07 (6.61) 
Note. Objective cognitive = objective psychometric neuropsychological test measures; S-NAB = 
Neuropsychological Assessment Battery Screening module; Subjective cognitive = subjective self-report 
of cognitive functioning; PDQ = Perceived Deficits Questionnaire; PCIQ = Perceived Cognitive 
Impairment Questionnaire; PHQ-9 = Patient Health Questionnaire; GAD-7 = Generalized Anxiety 
Disorder Scale. 





Bivariate Correlations Among Variables in the Depressed Group (N = 45) 
 
Measure 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1. S-NAB (A) −               
2. S-NAB (L)  .21 −              
3. S-NAB (M)  .31*  .24 −             
4. S-NAB (V)  .30*  .42**  .45* −            
5. S-NAB (EF)  .54**  .19  .62**  .48** −           
6. PDQ (A) -.44** -.19 -.18 -.19 -.37* −          
7. PDQ (M) -.12  .10  .13  .10 -.13 .71** −         
8. PDQ (EF) -.31* -.08 -.12 -.14 -.30* .74** .65** −        
9. PCIQ (L) -.15 -.07  .13  .02 -.11 .68** .75** .50** −       
10. PCIQ (V) -.07  .18  .10 -.05 -.16 .35* .60** .46** .38* −      
11. SDS (W) -.14 -.35* -.00 -.01 -.03 .53** .38* .46** .40** .58 −     
12. SDS (S) -.20 -.30* -.13 -.14 -.12 .63** .47** .54** .54** .00 .65** −    
13. SDS (F) -.37* -.15 -.18 -.06 -.28 .56** .48** .54** .47** .05 .60** .68** −   
14. PHQ-9  .18 -.19 -.24 -.28 -.12 .46** .40** .47** .45** .24 .42** .43** .55** −  
15. GAD-7 -.20 -.01 -.25 -.14 -.11 .40** .33* .38* .17 .17 .36* .31* .44** .74** − 
Note. S-NAB (A) = Neuropsychological Assessment Battery Screening module attention subscale; S-NAB (L) = Neuropsychological Assessment 
Battery Screening module language subscale; S-NAB (M) = Neuropsychological Assessment Battery Screening module memory subscale; S-NAB 
(V) = Neuropsychological Assessment Battery Screening module visuospatial subscale; S-NAB (EF) = Neuropsychological Assessment Battery 
Screening module executive functioning subscale; PDQ (A) = Perceived Deficits Questionnaire attention subscale; PDQ (M) = Perceived Deficits 
Questionnaire memory subscale; PDQ (EF) = Perceived Deficits Questionnaire executive functioning subscale; PCIQ (L) = Perceived Cognitive 
Impairment Questionnaire language subscale; PCIQ (V) = Perceived Cognitive Impairment Questionnaire visuospatial subscale; SDS (W) = 
Sheehan Disability Scale work subscale; SDS (S) = Sheehan Disability Scale social subscale; SDS (F) = Sheehan Disability Scale family subscale; 
PHQ-9 = Patient Health Questionnaire; GAD-7 = Generalized Anxiety Disorder Scale. 
*p < .05.   
**p < .01.  
  









(n = 45) 
Control 
(n = 29) 
Currently on psychiatric medications 19 (42.2%) 0 
Type of psychiatric medication   
SSRIs 11 (24.4%) 0 
SNRIs 6 (13.3%) 0 
NDRIs 4 (8.9%) 0 
NaSSAs 4 (8.9%) 0 
Atypical antidepressants 2 (4.4%) 0 
Mood stabilizers 5 (11.1%) 0 
Antipsychotics 7 (15.6%) 0 
Benzodiazepines 12 (26.7%) 0 
Stimulants 6 (13.3%) 0 
Note. SSRIs = selective serotonin reuptake inhibitors; SNRIs = selective norepinephrine 
reuptake inhibitors; NDRIs = norepinephrine dopamine reuptake inhibitors; NaSSAs = 













Appendix A: DSM-5 Diagnostic Criteria for Major Depressive Episode 
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DSM-5 Diagnostic Criteria for Major Depressive Disorder and Major Depressive Episode 
A. Five (or more) of the following symptoms have been present during the same 2 week 
period and represent a change from previous functioning: at least one of the symptoms is 
either (1) depressed mood or (2) loss of interest or pleasure.  
Note: Do not include symptoms that are clearly attributable to another medical condition. 
1. Depressed mood most of the day, nearly every day, as indicated by either subjective 
report (e.g. feels sad, empty, hopeless) or observation made by others (e.g. appears 
tearful). (Note: in children and adolescents, can be irritable mood.) 
2. Marked diminished interest or pleasure in all, or almost all activities most of the day, 
nearly every day (as indicated by either subjective account or observation). 
3. Significant weight loss when not dieting or weight gain (e.g. a change of more than 5% of 
body weight in a month), or decrease or increase in appetite nearly every day (Note: in 
children, consider failure to make expected weight gain.) 
4. Insomnia or hypersomnia nearly every day. 
5. Psychomotor agitation or retardation nearly every day (observable by others, not merely 
subjective of restlessness or being slowed down). 
6. Fatigue or loss of energy nearly every day. 
7. Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or guilt about being sick). 
8. Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by 
subjective account or as observed by others). 
9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a 
specific plan, or a suicide attempt or a specific plan for committing suicide. 
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B. The symptoms cause clinically significant distress or impairment in social, occupational, 
or other important areas of functioning. 
C. The episode is not attributable to the physiological effects a substance or to another 
medical condition. 
Note: Responses to a significant loss (e.g. bereavement, financial ruin, losses form a natural 
disaster, a serious medical illness or disability) may include the feelings of intense sadness, 
rumination about the loss, insomnia, poor appetite, and weight loss noted in Criterion A, which 
may resemble a depressive episode.  Although such symptoms may be understandable or 
considered appropriate to the loss, the presence of a major depressive episode in addition to the 
normal response to a significant loss should also be carefully considered.  This decision 
inevitably requires the exercise of clinical judgment based on the individual’s history and the 
cultural norms for the expression of distress in the context of loss. 
D. The occurrence of the major depressive episode is not better explained by schizoaffective 
disorder, schizophrenia, schizophreniform disorder, delusional disorder, or other specific 
and unspecified schizophrenia spectrum and psychotic disorders. 
E. There has never been a manic episode or a hypomanic episode. 
Note: This exclusion does not apply if all of the manic-like or hypomanic-like episodes 
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Appendix C: UTSC Ethics Board Approval Letter 
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FW: Thesis in Psychology Ethics Protocol Submission Inbox x 




Subject: Re: Thesis in Psychology Ethics Protocol Submission 
Date: Thu, 10 Sep 2015 09:34:20 -0400 
To: gausi@live.com 
 
Good morning Gausiha, 
 
I have received approval for your protocol and the protocol number 2015-2 has been assigned. 






Assistant to the Chair 
Department of Psychology 
University of Toronto Scarborough 
1265 Military Trail, Room S427!B 













Appendix D: List of Disorders Assessed by the M.I.N.I. 
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List of Disorders Assessed by the M.I.N.I. 
 
Disorder Past Current Lifetime 
Major depressive 
episode 
X X  
Suicidality  X X 
Manic and 
hypomanic episodes 
X X  
Panic disorder  X X 
Agoraphobia  X  
Social phobia  X  
Specific phobia  X  
Obsessive 
compulsive disorder 
 X  
Post traumatic stress 
disorder 
 X  
Alcohol 
dependence/abuse 
 X  
Substance 
dependence/abuse 
 X  
Psychotic disorders 
and mood disorder 
with psychotic 
features 
 X X 
Anorexia nervosa  X  
Bulimia nervosa  X  
General anxiety 
disorder 




  X 
 
  








Appendix E: Patient Health Questionnaire (PHQ-9) 
  





Over the last 2 weeks, how often have you been bothered 
by any of the following problems?                                                            More         Nearly 
(Use “✔” to indicate your answer)                                         Several      than half       every 
                                                                          Not at all         days      of the days       day 
 
1. Little interest or pleasure in doing things           0                    1                2                3 
 
2. Feeling down, depressed, or hopeless                0                    1                2                3 
 
3. Trouble falling or staying asleep,                       0                    1                2                3 
     or sleeping too much  
 
4. Feeling tired or having little energy                   0                     1                2               3 
 
5. Poor appetite or overeating                                 0                    1                2                3 
 
6. Feeling bad about yourself —                              
    or that you are a failure or                                  0                    1                2                3 
    have let yourself or your family  
 
7. Trouble concentrating on things,                       0                    1                2                3 
    such as reading the newspaper or  
    watching television  
 
8. Moving or speaking so slowly that other  
    people could have noticed? Or the opposite –   0                    1                2                3 
    being so fidgety or restless that you have been  
    moving around a lot more than usual 
 
9. Thoughts that you would be better off dead      0                    1                2                3 
    or of hurting yourself in some way 
 
                                    FOR OFFICE CODING    0             + ______ + ______ + ______ =   
                                                                                                                Total Score: ______ 
 
 
If you checked off any problems, how difficult have these problems made it for you to do your 
work, take care of things at home, or get along with other people? 
 
Not difficult                        Somewhat                        Very                        Extremely 
     at all                                  difficult                        difficult                      difficult 
 
  








Appendix F: Generalized Anxiety Disorder Scale (GAD-7) 





Over the last 2 weeks, how often have you been bothered 
by any of the following problems?                                                            Over         Nearly 
                                                                          Not at all      Several        half of        every 
                                                                               sure            days         the days       day 
 
1. Feeling nervous, anxious, or on edge                 0                    1                2                3 
 
2. Not being able to stop or control worrying        0                    1                2                3 
 
3. Worrying too much about different things         0                    1                2                3 
 
4. Trouble relaxing                                                 0                     1                2               3 
 
5. Being so restless that it's hard to sit still             0                    1                2                3 
 
6. Becoming easily annoyed or irritable                 0                    1                2                3 
 
7. Feeling afraid as if something awful might        0                    1                2                3 
     happen   
 
Add the score for each column                            ____     +       ____   +  ____      +   ____          
Total Score (add your column scores) =              
  
If you checked off any problems, how difficult have these made it for you to do your work, take 
care of things at home, or get along with other people?  
  
Not difficult at all __________  
Somewhat difficult _________  
Very difficult _____________  



















Appendix G: Perceived Deficits Questionnaire (PDQ) 
  






Please select the appropriate response based on your cognitive functioning during the 
past 4 weeks, including today. If you are not sure which answer to select, please choose the one 
that comes closest to describing you. 
 
During the past 4 weeks, how often did you… 
 
Never                  Rarely                  Sometimes                  Often                 Almost Always 
     0                         1                               2                              3                               4 
 
______ Lose your train of thought when speaking? 
______ Have difficulty remembering the names of people, even ones you have 
             met several times? 
______ Forget what you came into the room for? 
______ Have trouble getting things organized? 
______ Have trouble concentrating on what people are saying during a conversation? 
______ Forget if you had already done something? 
______ Miss appointments and meetings you had scheduled? 
______ Have difficulty planning what to do in a day? 
______ Have trouble concentrating on things like watching a television program or     
 reading a book? 
______ Forget what you did the night before? 
______ Forget the date unless you looked it up? 
______ Have trouble getting started, even if you had a lot of things to do? 
______ Find your mind drifting? 
______ Forget what you talked about after a phone conversation? 
______ Forget to do things like turn off the stove or turn on your alarm clock? 
______ Feel like your mind went totally blank? 
______ Have trouble holding phone numbers in your head, even for a few seconds? 
______ Forget what you did last weekend? 
______ Forget to take your medication? 
______ Have trouble making decisions? 
 
  








Appendix H: Perceived Cognitive Impairment Questionnaire (PCIQ) 
  






Everyone at some point experiences problems with memory, attention, or concentration, but 
these problems may occur more frequently for some individuals. The following questions 
describe several situations in which a person may encounter such problems. 
 
Please select the appropriate response based on your cognitive functioning during the 
past 4 weeks, including today. If you are not sure which answer to select, please choose the one 
that comes closest to describing you. 
 
During the past 4 weeks, how often did you… 
 
Never                  Rarely                  Sometimes                  Often                 Almost Always 
     0                         1                               2                              3                               4 
 
______ Become easily distracted? 
 
______ Lose your train of thought? 
 
______ Have difficulties understanding simple verbal instructions? 
 
______ Have trouble finding words for people’s names or things? 
 
______ Forget where you leave things? 
 
______ Find it difficult to follow and instruction that only has pictures of what you 
             needed to do? 
 
______ Find it hard to learn when someone showed you how to do something 
             visually, rather than telling you verbally? 
 
______ Forget things that people tell you? 
 
______ Have trouble remembering stories? 
 
______ Become clumsy? 
 
______ Have a hard time putting things together with your hands (and not because of 
             pain or physical limitations)? 
 
______ When you reach for things, feel your accuracy is off? 
 
______ Have problems with recognizing common objects, familiar scenes, or faces of 
 people you know? 
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______ Have difficulties recognizing common objects (e.g. a car) if they were seen from 
 different angles (e.g. front, side, rear)? 
 
______ Experience problems with writing or drawing because you were not able to 
 mentally put together the lines and curves to produce what you wanted to write or 
 draw? 
 
______ Have difficulty with planning or organizing daily activities? 
 
______ Find yourself talking more slowly? 
  








Appendix I: Sheehan Disability Scale (SDS) 










 Because of my problems my work is impaired 
 
 
0         1            2            3            4            5            6            7            8            9             10 
Not                Mildly                           Moderately                         Markedly                 Very 




S Social life/leisure activities 
 
(with other people at parties, socializing, visiting, dating, outings, clubs, entertaining) 
 
Because of my problems my social life is impaired 
 
 
0         1            2            3            4            5            6            7            8            9             10 
Not                Mildly                           Moderately                         Markedly                 Very 




F Family life/home responsibilities 
 
(relating to family members, paying bills, managing home, shopping and cleaning) 
 
Because of my problems my family life/home responsibilities are impaired 
 
 
0         1            2            3            4            5            6            7            8            9             10 
Not                       Mildly                           Moderately                         Markedly                 Very 




































Dear Patients of the START Clinic, 
 
Just before your first visit to the START Clinic, you are asked to complete a series of 
questionnaires which allow us the opportunity to assess you and your mental health.  The 
information gathered from the packages is used individually to aid in your assessment. In 
addition, it may be added together with the information from other people to examine generally 
what people are like when they arrive in the clinic. 
This information is very important for us and other therapists of patients with anxiety disorders 
in order to study and develop new treatment options that we can in turn offer our patients.   
Please be aware that all of the information you provide us with is kept with strict confidentiality, 
and also be aware that your name will not be used in any publications. 
If you have any further questions regarding the questionnaires used or the research we are 




Dr. Martin Katzman B.Sc., MD, FRCP(C ) 
Clinic Director 
 
I _____________________________________understand and am comfortable with the above. 
 Patient Name (PLEASE PRINT) 
 
_____________________________________ ____________________________ 
Signature       Date 
 
  








Appendix K: UTSC Consent Form 
  





Title of Study: On the Predictive Validity of Neuropsychological Testing and Real World 
Function 
Supervisor: Konstantine Zakzanis, Ph.D, C.Psych. 
zakzanis@utsc.utoronto.ca 
Investigator:  Gausiha Rathitharan 
 Gausiha.rathitharan@mail.utoronto.ca  
   
Overview: 
You are invited to participate in a study that aims to investigate the predictive validity of 
neuropsychological testing and real world function. 
This study is not part of any treatment. It is expected that 150 participants will be enrolled. 
It is important to know about the potentials risks and benefits of the study in order to make an 
informed decision to participate or not.  This consent form gives you detailed information about 
the research study. Once you understand the study, you will be asked if you wish to participate; 
if so, you will be asked to check yes at the bottom of this form.  
Voluntary Participation: 
Your participation in this study is entirely voluntary. You can choose to not participate, or to 
withdraw from the study at any time, and this will not have any foreseen undesirable 
consequences.  If you withdraw from the study, all information collected to that point will be 
retained within the study records. 
Benefits: 
The benefit of participation in this study is an opportunity to contribute to scientific research in 
clinical neuropsychology which will provide insight into the validity of neuropsychological 
testing.  
Student participants enrolled in TAPS will be rewarded with a time completion on the TAPS 
system leading to a course credit. Participants will be reimbursed for their participation on a pro-
rated basis, in increments of 30 minutes. 
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Description of Procedures: 
During this study you will be asked some questions related to any medical history, and to 
complete a series of computerized tasks.  Afterwards, you will complete some self-report 
questionnaires about your daily activities and emotional experiences.  You have the right to 
refuse to answer questions or withdraw from the study if you wish. 
This study is expected to take 3 hours.  
Risks: 
During the study you may feel mild fatigue or discomfort when completing some of the tasks.  If 
needed you may take breaks during the study. 
Exclusion from the Study: 
You will not be eligible for participation in this study if you are under 17 years of age or lack 
fluency in English.  
Confidentiality: 
All information collected about you during this study will be kept confidential and your 
identity will not be revealed when the results of this study are reported in presentations 
and publications. Your confidentiality will be protected. 
As part of continuing review of the research, your study records may be assessed on behalf of the 
Research Ethics Board. A person from the research ethics team may contact you, if your contact 
information is available to ask you questions about the research study and your consent to 
participate. The person assessing your file or contacting you must maintain your confidentiality 
to the extent permitted by law. 
New Information: 
If new information becomes available that is relevant to your participation or continuation in this 
study, you will be informed in a timely manner. 
Contacts: 
If you have any further questions about the study, you may contact Dr. Konstantine Zakzanis at 
zakzanis@utsc.utoronto.ca or Gausiha Rathitharan at Gausiha.rathitharan@mail.utoronto.ca. If 
you have any questions about your rights as a study participant, you may contact the Research 
Ethics Office at ethics.review@utoronto.ca, at 416-946-3273. 
Conflicts of Interest 
There are no foreseen conflicts of interest with respect to this study.   




I, ________________________________________________________(name of study 
participant) have read the information form for the study named “On the predictive validity of 
neuropsychological testing and real world function”. I understand that my role is that of a 
participant in this study. I have been given an opportunity to ask questions about this study. Any 
questions that I have had have been answered to my satisfaction, so that I now understand the 
study procedures, the potential risks of participating, and my right to the confidential treatment 
of the information that is collected about me. I also understand that my participation in this study 
is entirely voluntary, and that I may refuse to participate or withdraw from the study at any time, 





Participant’s Printed Name  
___________________________ 
















Signature & Date 
 
  








Appendix L: Medical Questionnaire 















Appendix M: Socio-demographic Questionnaire 
  









































Appendix N: UTSC Debriefing Form 
  





Thank you for your participation in the study “On the predictive validity of 
neuropsychological testing and real world function.”  
Historically, Clinical Neuropsychology was developed to assist with the diagnosis of 
brain pathology and neuropsychological assessments were successful in doing so. However, 
results obtained from neuropsychological assessments may not always correspond to everyday 
functioning. Ecological validity is the degree to which test performance corresponds to real 
world functioning. It is important to demonstrate that neuropsychological tests have ecological 
validity as the recommendations made by neuropsychologists depending on these measures can 
have dire consequences if the results are not applicable.  
In this study, you were asked to perform some neuropsychological tasks, questionnaires 
and a computerized task. These will allow us to measure your activities of daily living and we 
hypothesize that results from the neuropsychological measurements will correlate with those 
from the Activities of Daily Living measures.   
We ask that you do not disclose any information about this experiment, especially anything on 
this debriefing form, to any of your peers or colleagues, as we do not want any prior knowledge 
of our participants to bias the results of our study. This can ultimately lead to the publication of 
non-credible data. We thank you in advance for your cooperation.  
 This research is being supervised by a board certified and licensed clinical psychologist 
(i.e. Dr. Zakzanis). To begin, results will be reviewed by the psychologist. Should you express 
any concern as a result of completing any of the measures, the psychologist will review your 
responses with you and assess (informally) whether you might want to seek aid for a more 
formal matter (i.e. mental health issue) by way of Health and Wellness at UTSC.” 
If you have any further questions about the study, you may contact Dr. Konstantine 
Zakzanis at zakzanis@utsc.utoronto.ca or Gausiha Rathitharan at 
Gausiha.rathitharan@mail.utoronto.ca. 
 
 
